Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,A1BG,Alpha-1B-glycoprotein,19494,1852,1.43 [1.10-1.87],0.0083352503242925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,18799,1796,1.32 [1.17-1.49],4.333512882507211e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABL1,Tyrosine-protein kinase ABL1,22222,2129,1.13 [1.07-1.20],2.1885894282538523e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",21834,2088,1.33 [1.27-1.39],7.216950196746845e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,22107,2112,0.47 [0.41-0.54],1.918401258585996e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,19470,1855,1.70 [1.45-1.99],5.728747877068359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,21913,2105,1.76 [1.66-1.86],7.731169426272672e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACHE,Acetylcholinesterase,19045,1813,1.28 [1.12-1.46],0.0003053407826821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22331,2138,1.09 [1.01-1.17],0.0200628826502649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18885,1799,0.90 [0.81-1.00],0.0413300369858215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,22448,2148,1.96 [1.78-2.15],8.943956885286186e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,18885,1799,1.06 [1.01-1.12],0.0199900313696187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,22101,2129,1.21 [1.05-1.40],0.0103607512513407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,22331,2138,1.85 [1.76-1.96],3.102019106997164e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18799,1796,1.59 [1.48-1.70],9.12707020095118e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA,Adenosine deaminase,22551,2158,1.26 [1.14-1.40],6.989636830381748e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,22230,2119,1.96 [1.81-2.13],1.4163174365619574e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18885,1799,1.35 [1.18-1.54],1.1667022604084793e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,21913,2105,1.27 [1.12-1.44],0.0001431790181466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22468,2154,1.38 [1.21-1.56],9.32368459593714e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19369,1846,1.48 [1.29-1.70],2.101784200547832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22606,2166,2.20 [1.87-2.59],1.8608546186983018e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22222,2129,1.23 [1.12-1.35],7.963858583230269e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,18885,1799,1.17 [1.03-1.33],0.0164679354041855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22422,2149,0.84 [0.77-0.92],6.829882354422715e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,19475,1856,3.13 [2.83-3.46],1.4907715955438425e-111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL5,ADAMTS-like protein 5,19462,1849,0.87 [0.77-0.97],0.0143957272887794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,22101,2129,1.26 [1.12-1.41],6.857681446021463e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,19045,1813,1.87 [1.67-2.08],6.267988565326525e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,19369,1846,1.18 [1.09-1.27],3.744108270419099e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,22429,2152,1.81 [1.59-2.06],4.582637616712277e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,22515,2156,1.82 [1.64-2.03],3.183037233562391e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRF5,Adhesion G protein-coupled receptor F5,19462,1849,1.22 [1.04-1.43],0.0171972690966954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,22222,2129,1.50 [1.45-1.55],7.778057630146173e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,22331,2138,0.42 [0.36-0.48],6.850584794538575e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,19045,1813,1.37 [1.30-1.45],7.13500357932264e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,21913,2105,1.47 [1.41-1.54],2.393762999057881e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,19494,1852,0.54 [0.51-0.58],5.08969122126903e-79
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,22508,2152,1.50 [1.29-1.74],8.970400158239796e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADRA2A,Alpha-2A adrenergic receptor,18799,1796,0.92 [0.86-0.99],0.0228314703364956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,19494,1852,3.68 [2.95-4.58],2.81540360305313e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,22060,2123,0.90 [0.85-0.96],0.0010555705670899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGER,Advanced glycosylation end product-specific receptor,22291,2137,0.91 [0.83-1.00],0.0435339037085901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,21647,2071,1.18 [1.14-1.23],3.211365540079603e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,21787,2083,1.35 [1.28-1.44],1.6997419155643e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,22429,2152,1.77 [1.62-1.94],1.371736171408658e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,22551,2158,1.31 [1.22-1.41],4.811035158444993e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGT,Angiotensinogen,19470,1855,1.23 [1.02-1.49],0.0309047103606983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,22331,2138,1.39 [1.33-1.46],1.6891446389091066e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSG,Alpha-2-HS-glycoprotein,19470,1855,1.58 [1.34-1.86],5.6110942702928615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSP,Alpha-hemoglobin-stabilizing protein,22312,2144,1.05 [1.00-1.10],0.0339192951377967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22189,2127,1.14 [1.10-1.18],8.025601673897648e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKAP12,A-kinase anchor protein 12,19045,1813,0.58 [0.46-0.73],2.492908916773596e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,18933,1813,1.35 [1.28-1.43],8.296040825633781e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1C4,Aldo-keto reductase family 1 member C4,21913,2105,1.17 [1.10-1.25],1.537815177411306e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18885,1799,1.38 [1.31-1.45],1.9387891283897984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT1S1,Proline-rich AKT1 substrate 1,21826,2083,1.08 [1.02-1.15],0.0107071580693165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,22606,2166,2.28 [1.89-2.74],3.1884819449672825e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,22355,2147,1.48 [1.39-1.57],6.424530692795225e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19371,1841,1.10 [1.02-1.19],0.01320825172337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22234,2132,1.29 [1.24-1.34],4.0436209083744207e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19419,1844,1.19 [1.09-1.30],0.0001896980852929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,18885,1799,1.07 [1.03-1.11],0.0004443808507981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPP,"Alkaline phosphatase, placental type",22222,2129,1.11 [1.07-1.16],1.907809693960683e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,22471,2151,2.16 [1.80-2.59],1.3746882726701181e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMFR,E3 ubiquitin-protein ligase AMFR,21826,2083,1.09 [1.02-1.16],0.0066861121981019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO1,Amphoterin-induced protein 1,18933,1813,0.90 [0.81-0.99],0.0352942082092693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,22222,2129,1.79 [1.51-2.11],5.413756581962485e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMN,Protein amnionless,21900,2081,1.16 [1.07-1.26],0.0002957775526155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,19045,1813,1.54 [1.38-1.72],1.9143524116361964e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18219,1739,0.78 [0.71-0.86],3.677706416105521e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2A,Pancreatic alpha-amylase,21444,2052,0.76 [0.70-0.83],7.978666803571491e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2B,Alpha-amylase 2B,20800,1990,0.75 [0.69-0.81],3.992862591844653e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,22310,2134,1.32 [1.18-1.48],6.41137196126973e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,22508,2152,1.83 [1.67-2.01],2.3992873185927863e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL1,Angiopoietin-related protein 1,22016,2100,1.17 [1.02-1.34],0.024872195758115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,22358,2148,1.68 [1.53-1.84],1.0556708786074048e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,22375,2141,0.46 [0.41-0.51],7.341399664977051e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,22391,2150,1.31 [1.21-1.43],4.897062872217617e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,22508,2152,1.82 [1.66-2.01],8.497842276242405e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANPEP,Aminopeptidase N,22427,2137,1.44 [1.26-1.64],5.1156267989497616e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,21826,2083,1.14 [1.09-1.19],1.9686777750595744e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA11,Annexin A11,22249,2134,1.06 [1.00-1.13],0.0427026830990328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA2,Annexin A2,18665,1782,1.13 [1.06-1.20],0.0001402533104293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA3,Annexin A3,22468,2154,1.06 [1.00-1.12],0.0426055450780467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,21756,2077,1.22 [1.07-1.39],0.0026346529009583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,22460,2144,2.60 [2.29-2.94],2.3119937450363943e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP1G2,AP-1 complex subunit gamma-like 2,19371,1841,1.09 [1.03-1.15],0.0024990693917989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3B1,AP-3 complex subunit beta-1,19369,1846,1.06 [1.00-1.13],0.0373668009912746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22222,2129,1.20 [1.10-1.30],1.266485176599742e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22428,2147,1.13 [1.06-1.20],0.0001903276862493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,22331,2138,0.81 [0.75-0.87],6.165737855616293e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,19494,1852,0.41 [0.34-0.49],3.0277460383491705e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA2,Apolipoprotein A-II,19470,1855,0.91 [0.83-0.99],0.0363006826439237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,19494,1852,1.53 [1.38-1.71],5.307270220760566e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOBR,Apolipoprotein B receptor,18968,1809,0.87 [0.78-0.96],0.007283304388869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,19460,1848,0.37 [0.33-0.42],9.886819353401606e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,18662,1767,0.33 [0.29-0.38],6.292257518197226e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,19494,1852,0.85 [0.78-0.92],2.969225925429712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,19470,1855,0.49 [0.45-0.53],5.309270295649516e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,22355,2147,1.18 [1.07-1.30],0.0014014318837142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,19470,1855,0.87 [0.81-0.95],0.0008747676001621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,22412,2141,0.32 [0.28-0.36],3.975738709355709e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APP,Amyloid-beta precursor protein,22329,2143,1.06 [1.00-1.13],0.0349405766825713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APRT,Adenine phosphoribosyltransferase,22087,2128,1.10 [1.02-1.20],0.0199812076592443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,22222,2129,1.92 [1.78-2.07],6.682549709224162e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARF6,ADP-ribosylation factor 6,19369,1846,1.05 [1.01-1.10],0.014452077451691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP1,Rho GTPase-activating protein 1,21834,2088,0.91 [0.84-1.00],0.0429224938677861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,19425,1849,1.07 [1.02-1.13],0.0058127995574056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,22279,2137,1.05 [1.01-1.09],0.0147657599102089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,18824,1792,0.89 [0.82-0.97],0.0063139128461944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,22355,2147,1.35 [1.25-1.46],2.603524567597506e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSB,Arylsulfatase B,22222,2129,1.16 [1.08-1.24],2.9032396592456723e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,22460,2144,0.80 [0.72-0.89],3.914210776706873e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,19269,1841,1.28 [1.19-1.39],9.225329830451644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,22137,2130,1.64 [1.50-1.78],5.23218378252431e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,22137,2130,2.68 [2.40-2.98],1.9963045786479936e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,18799,1796,1.31 [1.24-1.39],1.0721539171002944e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18754,1788,1.15 [1.01-1.30],0.0368802586987829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG16L1,Autophagy-related protein 16-1,19369,1846,1.07 [1.02-1.13],0.0086278937741158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATOX1,Copper transport protein ATOX1,22422,2149,1.09 [1.03-1.15],0.0036023727648849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,18799,1796,0.91 [0.84-0.99],0.0247740856030062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6AP2,Renin receptor,21834,2088,1.14 [1.04-1.25],0.004853134935108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,19369,1846,1.17 [1.01-1.35],0.0306600350183377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",19494,1852,3.49 [2.72-4.47],5.674876128226133e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2L,Ataxin-2-like protein,19419,1844,1.11 [1.02-1.22],0.0181031242088363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXIN1,Axin-1,22279,2137,1.06 [1.02-1.10],0.0058644289702793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,22460,2144,1.28 [1.12-1.47],0.0003808242897247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZI2,5-azacytidine-induced protein 2,19419,1844,1.10 [1.02-1.20],0.0157990496318463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZU1,Azurocidin,21650,2086,1.06 [1.01-1.11],0.0244071610971393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,19494,1852,1.21 [1.08-1.35],0.0012203129932435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",18968,1809,2.35 [2.07-2.66],3.6649108002316927e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",22429,2152,1.57 [1.37-1.79],3.78459645882992e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BACH1,Transcription regulator protein BACH1,22279,2137,1.09 [1.03-1.15],0.0020174597024685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG3,BAG family molecular chaperone regulator 3,22101,2129,0.85 [0.78-0.93],0.0004418838286682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21834,2088,1.52 [1.44-1.59],2.2592669921424693e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,21834,2088,1.18 [1.03-1.34],0.0140253980324524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BANK1,B-cell scaffold protein with ankyrin repeats,22279,2137,1.07 [1.03-1.11],0.0003343282563557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAP18,Chromatin complexes subunit BAP18,19425,1849,1.10 [1.04-1.17],0.0017956204205679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,22355,2147,1.37 [1.18-1.59],3.226493716682821e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,22137,2130,0.52 [0.47-0.58],6.604404153554097e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCHE,Cholinesterase,19109,1818,1.73 [1.45-2.05],8.376883834056115e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22279,2137,1.16 [1.05-1.27],0.0026566795629137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L15,Bcl-2-like protein 15,18885,1799,1.19 [1.10-1.28],2.829160982451917e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCR,Breakpoint cluster region protein,22279,2137,1.07 [1.02-1.11],0.0024647585292621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BECN1,Beclin-1,18968,1809,1.14 [1.06-1.23],0.0007578962727551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,19475,1856,0.83 [0.79-0.87],7.528122849458095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BID,BH3-interacting domain death agonist,22279,2137,1.07 [1.01-1.13],0.0151070970217461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIN2,Bridging integrator 2,22355,2147,1.05 [1.00-1.09],0.0379194568147487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLMH,Bleomycin hydrolase,22606,2166,0.85 [0.75-0.95],0.0063740722966021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP4,Bone morphogenetic protein 4,22101,2129,1.23 [1.14-1.33],3.415249944608451e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP6,Bone morphogenetic protein 6,21885,2103,1.25 [1.14-1.38],3.519544169614684e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,19045,1813,2.95 [2.49-3.50],2.546169192435986e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,18885,1799,1.12 [1.01-1.24],0.0389014387181745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,21913,2105,1.19 [1.01-1.41],0.0432498392922688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB1,BPI fold-containing family B member 1,22277,2136,0.84 [0.79-0.89],6.489887904188456e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,19420,1848,1.24 [1.17-1.32],1.1662060340551344e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRAP,BRCA1-associated protein,19199,1826,1.05 [1.01-1.10],0.0226508155203033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRDT,Bromodomain testis-specific protein,18799,1796,1.14 [1.01-1.28],0.0370850961014306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22509,2156,1.16 [1.06-1.27],0.0011376818443624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,22509,2156,1.39 [1.30-1.47],4.4303216505960216e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTC,Probetacellulin,21834,2088,0.94 [0.89-0.99],0.0238511763094208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTD,Biotinidase,19494,1852,1.98 [1.58-2.48],2.165083197419782e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,22429,2152,1.55 [1.36-1.77],5.38691534402716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,22279,2137,1.20 [1.09-1.32],0.0001135018984383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,21826,2083,1.34 [1.28-1.41],4.795431833596804e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QA,Complement C1q subcomponent subunit A,22450,2151,1.19 [1.00-1.42],0.0443588722161155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QL2,Complement C1q-like protein 2,18885,1799,0.90 [0.81-0.99],0.0377693769227439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22460,2144,1.88 [1.74-2.02],5.2258178472080923e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19009,1810,0.84 [0.77-0.92],0.0001626059656481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,19456,1849,1.59 [1.26-2.00],8.333661188656452e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,22412,2141,3.18 [2.62-3.87],1.959258472865784e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2CD2L,Phospholipid transfer protein C2CD2L,21793,2082,1.11 [1.01-1.21],0.0230054328397449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,18470,1746,1.48 [1.36-1.60],8.013075338793527e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C4BPB,C4b-binding protein beta chain,22422,2149,0.83 [0.75-0.91],0.0001173903283016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C5,Complement C5,19494,1852,1.46 [1.08-1.97],0.0131060556291658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,19008,1806,2.51 [2.19-2.89],3.6850274515461e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,19470,1855,0.77 [0.72-0.83],5.2814127316728814e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,22222,2129,1.49 [1.33-1.67],8.344277413167917e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,22508,2152,0.48 [0.43-0.53],3.7871149181118135e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA3,Carbonic anhydrase 3,22571,2164,1.08 [1.02-1.15],0.0118262387742153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",21913,2105,1.21 [1.17-1.26],8.066324107779739e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,22291,2138,0.85 [0.80-0.90],1.274146168691649e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,22508,2152,1.31 [1.22-1.41],3.651702547825978e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19419,1844,1.07 [1.02-1.13],0.010758798575033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACYBP,Calcyclin-binding protein,19017,1812,1.05 [1.00-1.10],0.0315930588801503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,21826,2083,1.23 [1.12-1.35],1.80694476133854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,22104,2129,1.23 [1.16-1.29],2.2415399987742194e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,18968,1809,1.09 [1.03-1.16],0.0052523138215313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19419,1844,1.05 [1.00-1.09],0.0399132716438522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CANT1,Soluble calcium-activated nucleotidase 1,22253,2132,1.62 [1.34-1.95],3.50181685796434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,22131,2118,1.11 [1.04-1.19],0.0013472154590064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP2,Caspase-2,22279,2137,1.07 [1.01-1.13],0.0180099429241796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP9,Caspase-9,18885,1799,0.91 [0.85-0.99],0.0204119534842805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASQ2,Calsequestrin-2,18799,1796,0.87 [0.78-0.96],0.0084641704648074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,22288,2136,1.24 [1.18-1.30],8.1683313147079e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN4,Cerebellin-4,22508,2152,1.38 [1.24-1.53],2.777193922005157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,18968,1809,1.45 [1.36-1.56],3.783290610560096e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBX2,Chromobox protein homolog 2,18799,1796,0.87 [0.77-0.98],0.0247817301816207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22137,2130,1.07 [1.02-1.13],0.0083702167583058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC80,Coiled-coil domain-containing protein 80,22331,2138,1.13 [1.02-1.25],0.0224220619543857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,22551,2158,1.50 [1.35-1.66],1.8748425589223733e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL13,C-C motif chemokine 13,22516,2155,1.07 [1.01-1.13],0.0175751215062695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,22606,2166,1.79 [1.65-1.93],1.5754056354425138e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,22606,2166,1.43 [1.33-1.54],2.932842059892725e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL19,C-C motif chemokine 19,22509,2156,1.07 [1.04-1.10],8.49499901538448e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,22551,2158,1.23 [1.19-1.28],9.928311118647102e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,22429,2152,1.35 [1.26-1.44],3.989271933923503e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL22,C-C motif chemokine 22,22138,2124,1.19 [1.11-1.28],1.1293958572675898e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,22551,2158,1.31 [1.21-1.41],2.363603052114868e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL28,C-C motif chemokine 28,22197,2127,1.08 [1.01-1.15],0.0239988022748846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,22279,2137,1.17 [1.12-1.23],9.138899181039368e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL4,C-C motif chemokine 4,22364,2145,1.09 [1.03-1.14],0.0011003025886512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL5,C-C motif chemokine 5,22460,2144,1.07 [1.03-1.11],0.0002951143861321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,22279,2137,1.22 [1.15-1.29],6.409521725967459e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN1,CCN family member 1,22178,2127,1.13 [1.08-1.20],3.728771635526346e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,22567,2159,1.15 [1.04-1.28],0.0092194737912204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,22508,2152,1.45 [1.32-1.58],2.171723003516984e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,22355,2147,1.25 [1.13-1.37],1.0767637777869524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,19369,1846,1.29 [1.16-1.43],2.246583174358349e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,22355,2147,1.56 [1.39-1.75],3.2794717581624546e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,21936,2109,1.26 [1.15-1.38],1.0055014140059612e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,22551,2158,1.13 [1.05-1.22],0.0013697701664988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22460,2144,1.61 [1.49-1.75],7.911917617359849e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,22355,2147,1.41 [1.29-1.55],1.5656629682419157e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164L2,CD164 sialomucin-like 2 protein,18933,1813,0.83 [0.73-0.94],0.0036852789280463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,22422,2149,0.66 [0.57-0.77],5.97609559662644e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2,T-cell surface antigen CD2,18799,1796,1.19 [1.08-1.31],0.0005291949034689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200,OX-2 membrane glycoprotein,22279,2137,0.82 [0.71-0.94],0.0053052035162965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,22212,2130,1.22 [1.09-1.36],0.0003171199186874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,21827,2092,1.32 [1.20-1.46],4.0036422285689626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD209,CD209 antigen,22400,2149,0.80 [0.73-0.88],1.0613443051208603e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,22551,2158,1.35 [1.25-1.47],4.3318088996001554e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,22551,2158,1.56 [1.36-1.78],3.1983108884251993e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,19475,1856,0.58 [0.52-0.65],8.544201420567087e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,22422,2149,1.41 [1.30-1.54],1.5251945755156072e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,22137,2130,1.36 [1.22-1.51],9.650380141333197e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,22325,2139,1.68 [1.50-1.87],7.036812579383595e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,21834,2088,1.42 [1.30-1.56],8.160266377731533e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2AP,CD2-associated protein,22331,2138,1.12 [1.06-1.19],0.0001382262811099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,19045,1813,1.31 [1.14-1.52],0.0002007985104377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,22509,2156,1.43 [1.30-1.59],3.088044153808304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,22435,2146,1.24 [1.14-1.36],1.1936809948293829e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,22355,2147,0.57 [0.51-0.63],9.429160735029154e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,22222,2129,1.48 [1.32-1.66],2.0974445226261143e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD33,Myeloid cell surface antigen CD33,22422,2149,1.09 [1.04-1.15],0.0004972793307897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,22449,2154,0.49 [0.42-0.57],1.2845392572683033e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,18885,1799,1.13 [1.03-1.25],0.0115057514674118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22222,2129,1.34 [1.19-1.50],6.08661931757569e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,22242,2132,1.51 [1.36-1.67],7.444044442801928e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,22326,2143,1.18 [1.10-1.28],1.3537850175360876e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,22238,2125,1.27 [1.12-1.45],0.0002814634960591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,22391,2150,1.59 [1.41-1.79],8.625388145569383e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,22471,2151,1.49 [1.37-1.62],5.709176435467913e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD58,Lymphocyte function-associated antigen 3,22296,2136,0.79 [0.64-0.98],0.0313350495795115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,21568,2053,1.46 [1.25-1.70],1.447919486754102e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD6,T-cell differentiation antigen CD6,22519,2155,1.17 [1.09-1.26],1.165963896679002e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,22101,2129,1.27 [1.18-1.37],1.2938311613173075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD69,Early activation antigen CD69,22240,2128,1.07 [1.02-1.11],0.0046359739037822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,18840,1793,1.18 [1.06-1.30],0.0020189283297824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,19045,1813,1.30 [1.18-1.44],2.5717211248580776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,22509,2156,1.58 [1.43-1.75],3.600662468667532e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,22551,2158,1.21 [1.12-1.31],1.5118660637272075e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,19462,1849,2.11 [1.89-2.36],2.007976246383939e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,22279,2137,1.58 [1.42-1.75],1.4669474742401904e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,22509,2156,1.32 [1.23-1.42],7.569247809401888e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD93,Complement component C1q receptor,21533,2078,0.83 [0.73-0.94],0.0032744126546246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDA,Cytidine deaminase,19417,1845,1.14 [1.04-1.25],0.0044414690465622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC27,Cell division cycle protein 27 homolog,21834,2088,1.11 [1.04-1.18],0.0010771294209151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,22137,2130,1.47 [1.38-1.57],8.068020346578909e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,21625,2059,1.76 [1.64-1.90],2.459277958175366e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,22476,2155,1.36 [1.30-1.43],1.194389043725158e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,22331,2138,1.43 [1.36-1.51],2.5639579464182644e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,22331,2138,2.48 [2.24-2.74],3.9778312424168114e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,22331,2138,1.31 [1.19-1.44],7.524198002050243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR1,Cadherin-related family member 1,21826,2083,1.11 [1.02-1.21],0.0204414615038517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,22222,2129,1.48 [1.40-1.57],5.655084170444245e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR5,Cadherin-related family member 5,22331,2138,1.24 [1.12-1.38],2.741754993837925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK1,Cyclin-dependent kinase 1,18754,1788,1.23 [1.09-1.40],0.0009545221414335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,22222,2129,1.08 [1.04-1.12],1.602721756672825e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22359,2146,1.57 [1.36-1.83],3.1888981825117387e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDSN,Corneodesmosin,22483,2147,0.83 [0.76-0.91],3.7704567469978495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22385,2142,1.81 [1.53-2.14],2.803233307295392e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19369,1846,1.20 [1.13-1.27],6.71088753948031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19109,1826,1.26 [1.16-1.37],1.081868834484972e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22279,2137,1.06 [1.02-1.11],0.0066878899265865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21570,2065,1.21 [1.14-1.28],1.6947474313297387e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19475,1856,1.31 [1.19-1.45],5.064511972298815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21913,2105,1.21 [1.13-1.31],4.352425306709671e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPB,CCAAT/enhancer-binding protein beta,21913,2105,1.12 [1.02-1.24],0.0189850380252288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA2A,Chymotrypsin-like elastase family member 2A,19475,1856,0.90 [0.84-0.96],0.0029704687895667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA3A,Chymotrypsin-like elastase family member 3A,22573,2164,0.90 [0.85-0.96],0.0020919092346229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,18885,1799,1.45 [1.33-1.59],8.50610765121042e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP20,Centrosomal protein 20,21834,2088,1.10 [1.05-1.16],0.0001578582121531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP43,Centrosomal protein 43,21740,2092,1.11 [1.05-1.17],0.0003851196836643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP85,Centrosomal protein of 85 kDa,21834,2088,1.09 [1.03-1.16],0.0036206120584108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,22407,2150,1.43 [1.38-1.49],8.181194225373878e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,22222,2129,1.42 [1.34-1.51],2.764769780126706e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES3,Carboxylesterase 3,22222,2129,1.19 [1.13-1.25],4.838178105685762e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN2,Centrin-2,21826,2083,1.09 [1.03-1.15],0.0043731010681779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,19140,1808,2.11 [1.83-2.43],1.9531881649345893e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,21834,2088,1.30 [1.20-1.41],1.466487709213054e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFD,Complement factor D,19494,1852,0.66 [0.53-0.82],0.0002247264098652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,18338,1727,2.82 [2.30-3.46],2.090305518002238e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,19458,1849,0.85 [0.80-0.91],1.2690446184015609e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,19208,1828,0.85 [0.77-0.95],0.0027792526437284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,19494,1852,4.10 [3.26-5.15],1.1701693080996821e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,22355,2147,1.07 [1.01-1.14],0.0260330345065242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,22331,2138,1.44 [1.32-1.58],2.3551506204190554e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,19045,1813,0.52 [0.48-0.57],8.135785986183001e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19425,1849,1.65 [1.51-1.80],7.04517552693958e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,19371,1841,1.49 [1.31-1.70],1.266113053599523e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,19475,1856,1.12 [1.08-1.17],6.131287773523111e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,21891,2088,1.27 [1.21-1.32],6.010904742144634e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHL1,Neural cell adhesion molecule L1-like protein,22428,2141,0.65 [0.57-0.74],1.4781586102139055e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,22331,2138,1.34 [1.24-1.46],3.704597725536936e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,19475,1856,1.66 [1.52-1.82],4.182561970156854e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,22455,2149,1.38 [1.22-1.57],5.803371699189289e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,19475,1856,0.58 [0.53-0.62],5.550534572487459e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22263,2133,1.19 [1.12-1.26],2.36166126429025e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC12A,C-type lectin domain family 12 member A,18885,1799,1.25 [1.00-1.55],0.0468498374551116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1B,C-type lectin domain family 1 member B,22509,2156,1.06 [1.02-1.11],0.0022848421856925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,19030,1800,0.35 [0.28-0.43],2.2624289529309297e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,22279,2137,0.66 [0.60-0.73],1.503229717660878e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,22279,2137,1.24 [1.17-1.32],4.799968238293765e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,19440,1854,0.75 [0.68-0.82],5.98356771063958e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,22268,2132,1.18 [1.04-1.34],0.0106853097890663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,21834,2088,1.23 [1.14-1.34],2.0517362695049106e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,22551,2158,1.08 [1.01-1.16],0.0232528794556604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIP2,CAP-Gly domain-containing linker protein 2,22279,2137,1.06 [1.02-1.09],0.0020304661718787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22104,2129,1.07 [1.03-1.12],0.0006716937519372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPS,Colipase,22312,2144,0.94 [0.89-0.99],0.0255113044502074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,22551,2158,1.47 [1.34-1.60],1.2124108530548008e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN3,Calsyntenin-3,19425,1849,1.50 [1.30-1.72],1.2176770097703604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,22295,2134,0.72 [0.66-0.79],8.218282469363814e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",18932,1802,1.09 [1.03-1.15],0.0050358765245785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNST,Consortin,22331,2138,1.05 [1.02-1.09],0.0035638331628063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,22508,2152,1.26 [1.16-1.37],9.416463375334485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,22355,2147,2.64 [2.32-3.00],3.401864251755396e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,22355,2147,1.74 [1.48-2.03],8.180015493476621e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,22374,2145,0.77 [0.69-0.85],4.759505846855573e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,22279,2137,1.24 [1.13-1.35],1.938863424146964e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,19475,1856,0.59 [0.50-0.70],4.728070731056734e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,22449,2145,1.97 [1.68-2.30],3.2034518792208304e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,22606,2166,0.62 [0.53-0.73],5.833212305151923e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,19475,1856,2.12 [1.78-2.54],1.3636453088221762e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,22331,2138,1.33 [1.21-1.46],3.250307711317265e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,19045,1813,1.56 [1.41-1.73],2.4707281239197762e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,22606,2166,1.59 [1.44-1.75],6.283440181496005e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A1,Collagen alpha-1(IX) chain,22279,2137,0.83 [0.77-0.90],8.126755180591175e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,22325,2139,1.63 [1.42-1.86],2.668326295690044e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,22120,2107,0.75 [0.67-0.84],8.884335837873722e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22222,2129,1.09 [1.04-1.15],0.0012987281026415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX6B1,Cytochrome c oxidase subunit 6B1,19462,1849,1.19 [1.04-1.36],0.0091874311158173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,22444,2152,1.33 [1.25-1.40],2.3198302089703788e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA4,Carboxypeptidase A4,18667,1766,0.82 [0.73-0.91],0.0001581191868049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPE,Carboxypeptidase E,22315,2127,0.77 [0.70-0.84],1.8386095274284932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,22386,2142,3.14 [2.85-3.45],1.056917036157723e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,22509,2156,1.06 [1.00-1.13],0.0416750985993597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,19434,1854,1.54 [1.36-1.74],7.011530115704449e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPVL,Probable serine carboxypeptidase CPVL,22477,2150,1.24 [1.12-1.36],1.6089649393948617e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,19462,1849,1.42 [1.21-1.66],1.6665973331930855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,19396,1849,1.35 [1.19-1.53],1.80763787385624e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,22460,2144,1.36 [1.26-1.48],1.6509469353223677e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREB3,Cyclic AMP-responsive element-binding protein 3,18754,1788,0.91 [0.83-0.99],0.0288586742178182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,19045,1813,2.05 [1.82-2.31],1.281663949720945e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD2,Protein disulfide isomerase CRELD2,22391,2150,1.16 [1.08-1.25],4.09532652753225e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,21797,2086,0.79 [0.76-0.83],5.991111705499486e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,22325,2139,2.49 [2.17-2.86],6.377636694034826e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,22429,2152,1.26 [1.05-1.52],0.012528578725616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,22137,2130,1.38 [1.26-1.51],2.1666005428593165e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP2,Cysteine-rich secretory protein 2,22508,2152,0.87 [0.82-0.93],1.642994040761802e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,19298,1838,0.62 [0.53-0.73],3.588054532714309e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRLF1,Cytokine receptor-like factor 1,22429,2152,1.57 [1.35-1.83],6.946889041848909e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,21713,2076,0.85 [0.80-0.90],8.543676233734281e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,22606,2166,0.59 [0.52-0.66],8.039529636172109e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,22429,2152,1.90 [1.67-2.18],3.954634579106128e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,19470,1855,1.57 [1.41-1.74],2.24836531497428e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2,Granulocyte-macrophage colony-stimulating factor,18799,1796,1.29 [1.15-1.44],8.036326243113234e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22137,2130,1.17 [1.10-1.24],1.944322595930193e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3R,Granulocyte colony-stimulating factor receptor,18885,1799,1.19 [1.03-1.38],0.0190723311596112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK2A1,Casein kinase II subunit alpha,19419,1844,0.87 [0.79-0.97],0.0083291275954524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG4,Chondroitin sulfate proteoglycan 4,19475,1856,0.82 [0.71-0.93],0.0034698546319289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG5,Chondroitin sulfate proteoglycan 5,18824,1792,0.88 [0.80-0.97],0.0094756891123375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,22426,2139,1.58 [1.40-1.79],3.240370577680839e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST6,Cystatin-M,21728,2077,0.84 [0.77-0.90],7.730335722994071e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,22364,2145,1.11 [1.07-1.15],2.246618525527265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,22030,2109,1.24 [1.13-1.35],3.1881834812901337e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,19168,1827,2.26 [1.90-2.68],6.439674201573661e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,19475,1856,1.32 [1.14-1.53],0.0002289733322484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTNNA1,Catenin alpha-1,18824,1792,0.84 [0.73-0.97],0.0176523297530386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,22327,2146,0.82 [0.77-0.86],4.92660336540971e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRL,Chymotrypsin-like protease CTRL-1,19425,1849,0.83 [0.78-0.88],7.545279105955952e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,22381,2135,0.71 [0.66-0.77],7.29150033337996e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSC,Dipeptidyl peptidase 1,22283,2139,1.26 [1.15-1.37],1.0589628462366709e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,20932,2006,1.95 [1.82-2.08],3.8718687179271003e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,19045,1813,1.39 [1.28-1.52],4.2495944835149496e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSH,Pro-cathepsin H,21831,2102,1.10 [1.04-1.15],0.0004636803966077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,22331,2138,1.75 [1.51-2.04],2.474798521657704e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,22551,2158,2.79 [2.52-3.09],4.539849888711096e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,17465,1694,2.44 [2.02-2.95],1.3322810331456831e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,22399,2135,1.85 [1.65-2.07],3.090422028133418e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,18933,1813,1.17 [1.05-1.30],0.0059379018291006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CX3CL1,Fractalkine,22137,2130,0.79 [0.70-0.88],5.191324250524081e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,22279,2137,1.21 [1.13-1.30],2.549265057075396e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL11,C-X-C motif chemokine 11,22509,2156,1.05 [1.01-1.10],0.0224033014200934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,21900,2081,0.81 [0.73-0.89],3.524020948610732e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL13,C-X-C motif chemokine 13,22509,2156,1.14 [1.09-1.20],1.4325173574681768e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL14,C-X-C motif chemokine 14,21900,2081,1.06 [1.00-1.13],0.047065234478524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,22577,2164,1.66 [1.42-1.95],2.1529208599837623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,22551,2158,1.36 [1.25-1.48],1.2608787456456549e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL5,C-X-C motif chemokine 5,22264,2132,1.06 [1.02-1.09],0.0009201301822524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL6,C-X-C motif chemokine 6,22551,2158,1.14 [1.08-1.19],3.894169031212572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,22167,2116,1.14 [1.09-1.20],1.1752863808407341e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL9,C-X-C motif chemokine 9,22429,2152,1.08 [1.02-1.15],0.0065905977735719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5A,Cytochrome b5,18754,1788,1.08 [1.02-1.15],0.0066555005396514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,19475,1856,0.53 [0.45-0.64],6.742278165134118e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAAM1,Disheveled-associated activator of morphogenesis 1,19045,1813,1.07 [1.02-1.13],0.0098284511761986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAB2,Disabled homolog 2,22508,2152,1.04 [1.00-1.07],0.0334432110875773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,22429,2152,1.42 [1.31-1.54],5.665531491047203e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBI,Acyl-CoA-binding protein,22260,2137,1.07 [1.02-1.13],0.01004507046862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22422,2149,1.82 [1.64-2.02],6.050919381520778e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCC,Netrin receptor DCC,18933,1813,0.75 [0.60-0.94],0.0122195766047379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN1,Dynactin subunit 1,22508,2152,1.07 [1.01-1.14],0.0182097203256714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,22422,2149,1.49 [1.39-1.59],1.661102612064062e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22222,2129,1.40 [1.29-1.52],3.432964762033977e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDHD2,Phospholipase DDHD2,19419,1844,1.09 [1.02-1.16],0.0165472965299714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,22509,2156,1.82 [1.56-2.12],3.266732763014384e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDT,D-dopachrome decarboxylase,19475,1856,1.28 [1.16-1.42],8.925857210682382e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX25,ATP-dependent RNA helicase DDX25,18933,1813,0.83 [0.73-0.95],0.005997932035534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22279,2137,1.07 [1.03-1.11],0.0015517190911502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,18727,1785,1.27 [1.17-1.39],4.9971052999811706e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB4A_DEFB4B,Beta-defensin 4A,22033,2119,1.06 [1.03-1.08],3.800200726102884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKA,Diacylglycerol kinase alpha,18885,1799,1.09 [1.01-1.19],0.0369686158258371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHPS,Deoxyhypusine synthase,19371,1841,1.26 [1.16-1.38],3.6486641587878427e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,19045,1813,0.59 [0.50-0.69],2.376921543910382e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK1,Dickkopf-related protein 1,22509,2156,1.10 [1.03-1.18],0.0029100339492806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,22104,2126,1.45 [1.34-1.56],1.2110529006143072e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLK1,Protein delta homolog 1,22606,2166,1.14 [1.07-1.22],0.000116399608271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,22422,2149,1.48 [1.32-1.67],1.0445643490356364e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,18968,1809,1.13 [1.04-1.23],0.0040652526745622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,18968,1809,0.60 [0.57-0.64],3.7274021199109513e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA2,DnaJ homolog subfamily A member 2,22487,2152,1.09 [1.04-1.14],0.0004255274790812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB1,DnaJ homolog subfamily B member 1,22222,2129,1.06 [1.01-1.10],0.0172930858792203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,18968,1809,1.07 [1.02-1.13],0.0119421526797772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,22285,2144,0.84 [0.73-0.98],0.023373590164037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM3,Dynamin-3,19419,1844,1.08 [1.00-1.17],0.0488552548561288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNMBP,Dynamin-binding protein,22137,2130,1.09 [1.03-1.17],0.0057194940202035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPEP,Aspartyl aminopeptidase,19425,1849,1.28 [1.18-1.38],1.951448618862218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK2,Docking protein 2,22331,2138,1.04 [1.01-1.07],0.0160012977155072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPEP2,Dipeptidase 2,22222,2129,0.88 [0.77-1.00],0.0471834442578281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,22279,2137,1.50 [1.37-1.65],1.2926229386554679e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,22222,2129,1.95 [1.75-2.18],5.200524639704926e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP7,Dipeptidyl peptidase 2,22161,2123,1.20 [1.12-1.27],1.6917860772052937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,22606,2166,1.21 [1.03-1.41],0.0188264371474444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,22428,2147,1.28 [1.21-1.35],9.223156348063372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,22126,2125,1.57 [1.42-1.75],1.1531766222618378e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,19419,1844,1.75 [1.55-1.98],2.0307401633321009e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,22355,2147,0.64 [0.56-0.74],3.73282937780848e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG3,Desmoglein-3,22427,2147,0.85 [0.76-0.95],0.0048325165012828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,22156,2123,0.78 [0.72-0.84],1.6130219213355544e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,19327,1835,1.54 [1.40-1.70],2.911413625244805e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22222,2129,0.85 [0.72-1.00],0.0466914068487816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTYMK,Thymidylate kinase,19462,1849,1.08 [1.01-1.16],0.0184153671089428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19369,1846,1.09 [1.04-1.13],0.0001610693194494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT1,Dynein light chain Tctex-type 1,18933,1813,1.06 [1.00-1.12],0.0435793668086681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22137,2130,1.06 [1.02-1.11],0.0041056453574563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,22470,2148,1.16 [1.03-1.32],0.0170070725585885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19462,1849,1.29 [1.22-1.36],8.822076736716054e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",18968,1809,1.18 [1.13-1.24],1.574422865971658e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECI2,Enoyl-CoA delta isomerase 2,18799,1796,1.16 [1.08-1.24],1.7560942596858803e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECM1,Extracellular matrix protein 1,18979,1794,1.19 [1.05-1.35],0.0080053290553927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,22508,2152,1.38 [1.25-1.51],2.097985102014127e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDDM3B,Epididymal secretory protein E3-beta,19371,1841,0.79 [0.72-0.86],9.448574522820537e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,21913,2105,1.36 [1.22-1.52],2.6680442620282515e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,18968,1809,1.33 [1.15-1.55],0.0001990450912051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EEF1D,Elongation factor 1-delta,19462,1849,1.10 [1.04-1.15],0.0002356555906027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22431,2142,1.18 [1.05-1.33],0.0055191257720025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFHD1,EF-hand domain-containing protein D1,19419,1844,0.81 [0.71-0.93],0.0022634024885058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,22323,2146,1.43 [1.26-1.62],1.9533822134509564e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,22101,2129,1.94 [1.76-2.15],2.069180650376745e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,21834,2088,1.19 [1.09-1.31],0.0001614545991571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFLAM,Pikachurin,19369,1846,1.21 [1.05-1.39],0.0071724725026775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,22606,2166,0.65 [0.52-0.83],0.0004201181314816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,22279,2137,1.20 [1.13-1.27],2.5310991822157153e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22331,2138,1.11 [1.05-1.18],0.0003223816359983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22551,2158,1.09 [1.05-1.13],3.2287278787837004e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAVL4,ELAV-like protein 4,18824,1792,1.06 [1.01-1.12],0.0231478080589773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELN,Elastin,19462,1849,0.79 [0.69-0.89],0.0002248559906218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOA,Elongin-A,22222,2129,1.14 [1.07-1.21],4.600167991568529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENAH,Protein enabled homolog,21900,2081,1.10 [1.01-1.19],0.0221998521441181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENDOU,Poly(U)-specific endoribonuclease,17963,1732,0.91 [0.84-0.99],0.0359992661832626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENG,Endoglin,22606,2166,1.35 [1.09-1.68],0.0061463907609813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO1,Alpha-enolase,22305,2139,1.06 [1.01-1.11],0.0237893032734437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO3,Beta-enolase,18968,1809,1.25 [1.16-1.34],1.559667610572874e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22606,2166,1.44 [1.26-1.65],8.770810080813154e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21596,2064,1.28 [1.22-1.34],1.4784305525892474e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,21834,2088,1.41 [1.30-1.53],2.2272843487217058e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,21913,2105,0.57 [0.48-0.67],9.149728898849827e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,21913,2105,1.55 [1.33-1.81],2.5000362976878183e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTR1,Endosome-associated-trafficking regulator 1,18968,1809,1.18 [1.10-1.27],6.840619841330921e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,22316,2140,0.96 [0.92-1.00],0.027986946383432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPGN,Epigen,19371,1841,0.87 [0.78-0.98],0.0184948362623744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,22400,2149,1.36 [1.21-1.54],2.768127068543488e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,21514,2051,1.47 [1.32-1.64],7.345770025549317e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,19045,1813,1.18 [1.01-1.37],0.0379406681869852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,22606,2166,1.23 [1.06-1.42],0.0050867051329707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHX2,Bifunctional epoxide hydrolase 2,21913,2105,1.07 [1.01-1.13],0.0269050760019218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,22279,2137,1.17 [1.12-1.23],1.0841793699078359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22466,2151,1.81 [1.62-2.02],1.578296463829586e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,22422,2149,2.39 [2.05-2.79],5.29853577991483e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,22265,2136,1.41 [1.16-1.71],0.0005866046607026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,22422,2149,1.67 [1.43-1.95],8.8081286493233e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBIN,Erbin,22222,2129,1.05 [1.01-1.09],0.0218465501949951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EREG,Proepiregulin,22104,2129,1.05 [1.00-1.10],0.0374813618523936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,18885,1799,1.26 [1.14-1.40],7.293977423014374e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19371,1841,1.34 [1.20-1.49],1.961667222084377e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP44,Endoplasmic reticulum resident protein 44,22178,2127,1.22 [1.05-1.42],0.0084616120182732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,22606,2166,1.16 [1.03-1.30],0.0115313976530323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,22325,2139,0.63 [0.56-0.70],4.205751208700778e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESYT2,Extended synaptotagmin-2,19425,1849,1.08 [1.03-1.15],0.0035749373907416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXTL1,Exostosin-like 1,18799,1796,0.80 [0.72-0.89],4.7103329966172894e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,22509,2156,1.63 [1.41-1.88],3.6691469993614114e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,19470,1855,1.21 [1.04-1.40],0.0127964642651138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11,Coagulation factor XI,19216,1827,1.29 [1.12-1.48],0.0003900678990193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,22355,2147,1.25 [1.17-1.33],8.040945683934969e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,19380,1838,0.65 [0.55-0.78],1.4690388228338282e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2,Prothrombin,19494,1852,0.72 [0.54-0.97],0.0301419688503533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,22391,2150,1.12 [1.05-1.20],0.0008030305561637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F3,Tissue factor,22372,2140,0.75 [0.65-0.87],0.0001008244686903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F7,Coagulation factor VII,22424,2139,1.42 [1.26-1.61],2.8478164776970225e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,22412,2141,3.22 [2.62-3.95],6.199345873399897e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",22325,2139,1.40 [1.35-1.45],2.3985201567669785e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",22331,2138,1.10 [1.05-1.15],3.711883460013903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",19462,1849,1.39 [1.28-1.50],4.80867007584732e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",22606,2166,1.53 [1.43-1.64],4.55545051954878e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,22426,2151,1.18 [1.12-1.25],6.329530237599835e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP6,Gastrotropin,21871,2101,1.09 [1.02-1.16],0.0132030171516863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP9,Fatty acid-binding protein 9,22279,2137,0.88 [0.82-0.95],0.0003533572458763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,19462,1849,2.08 [1.84-2.36],6.200304756023349e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,22222,2129,1.62 [1.45-1.80],1.6231120357657078e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,22288,2136,2.04 [1.81-2.30],1.493824798472441e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,19369,1846,1.30 [1.24-1.37],3.051813185893688e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,22541,2159,1.38 [1.26-1.50],1.9137279156944426e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,22551,2158,0.66 [0.59-0.73],5.927362612287055e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBN2,Fibrillin-2,18933,1813,1.09 [1.01-1.18],0.0253163926759621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",22331,2138,1.24 [1.18-1.30],1.081030098389385e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19462,1849,1.53 [1.44-1.62],1.038565321027595e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,22279,2137,1.32 [1.22-1.42],4.3962787320596186e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19419,1844,1.25 [1.05-1.50],0.0147035959476493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22355,2147,1.12 [1.05-1.20],0.0010446162045506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22270,2131,1.09 [1.02-1.17],0.0139312628308586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN1,Ficolin-1,19425,1851,1.25 [1.14-1.36],4.673805307524135e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL1,Fc receptor-like protein 1,22331,2138,1.12 [1.03-1.21],0.0065530097701824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL5,Fc receptor-like protein 5,22355,2147,1.20 [1.12-1.27],4.244299298619675e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL6,Fc receptor-like protein 6,22279,2137,1.09 [1.04-1.16],0.0013307284198597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,21834,2088,1.14 [1.09-1.20],2.676104637957232e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",18799,1796,1.13 [1.05-1.20],0.0006272644576281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FEN1,Flap endonuclease 1,21834,2088,1.06 [1.01-1.12],0.0256954242278152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FETUB,Fetuin-B,22412,2141,1.52 [1.34-1.73],1.8061896132372047e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGA,Fibrinogen alpha chain,19035,1797,1.21 [1.04-1.40],0.0131912427662903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,22429,2152,0.89 [0.85-0.94],3.589046250620759e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF2,Fibroblast growth factor 2,22279,2137,1.06 [1.01-1.12],0.0306677460350501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,22470,2148,1.25 [1.21-1.29],8.105912181430748e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,22477,2147,1.33 [1.25-1.41],4.0278697218455123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,21900,2081,1.26 [1.13-1.42],7.12998913016046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,22422,2149,0.33 [0.30-0.37],9.496488412780512e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,19475,1856,0.79 [0.72-0.86],3.140535133188549e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,19425,1849,0.62 [0.54-0.70],1.75935128558198e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,22422,2149,3.66 [3.17-4.22],4.5195576823179845e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR4,Fibroblast growth factor receptor 4,19045,1813,0.87 [0.79-0.94],0.0009475400210429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,19470,1855,1.20 [1.12-1.29],9.882474793516853e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGR,Tyrosine-protein kinase Fgr,21826,2083,1.12 [1.06-1.19],0.0001380159030125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19419,1844,1.05 [1.00-1.09],0.0485170779710227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22137,2130,1.22 [1.12-1.34],1.4133637767842676e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22137,2130,1.05 [1.01-1.10],0.0187936196740228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLI1,Friend leukemia integration 1 transcription factor,21834,2088,1.04 [1.01-1.08],0.0195335875717253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22137,2130,1.36 [1.19-1.55],5.549735241544219e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,22551,2158,1.34 [1.20-1.49],2.5516337943473176e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT4,Vascular endothelial growth factor receptor 3,22422,2149,1.14 [1.01-1.28],0.0292983209530766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMNL1,Formin-like protein 1,21826,2083,1.11 [1.06-1.18],5.368768512255628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,22325,2137,1.16 [1.02-1.32],0.0200631620436915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,22391,2150,0.77 [0.71-0.84],3.7557798695758814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,18968,1809,1.39 [1.13-1.70],0.0014582330681944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,22287,2141,1.50 [1.34-1.68],4.679041674626471e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,19381,1843,1.49 [1.42-1.56],1.1877674162147654e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUCA1,Tissue alpha-L-fucosidase,22480,2155,1.08 [1.03-1.13],0.0019003916055734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,19045,1813,1.59 [1.49-1.70],4.3471335306677965e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,22422,2149,2.02 [1.80-2.27],2.006775604873509e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19070,1823,1.11 [1.04-1.19],0.0018868466557245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22509,2156,1.19 [1.10-1.29],1.1310918187154757e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FYB1,FYN-binding protein 1,22312,2144,1.08 [1.03-1.12],0.0005247561240531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,22429,2152,0.82 [0.78-0.87],7.970487821483179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22222,2129,2.23 [1.95-2.54],1.0812451030973784e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22508,2152,0.85 [0.73-0.97],0.0200679714824771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,21900,2081,1.46 [1.34-1.59],9.433800751332836e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,22222,2129,1.64 [1.36-1.97],1.2236518045954572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18613,1761,1.58 [1.35-1.85],1.9242754614809402e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS2,Growth arrest-specific protein 2,19109,1826,1.21 [1.13-1.30],1.3849351639297976e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,22481,2153,1.31 [1.12-1.52],0.0005694027701374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,19425,1849,1.10 [1.07-1.13],4.933811702913599e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP1,Guanylate-binding protein 1,19391,1848,1.12 [1.05-1.20],0.0012833625965937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCC1,GRIP and coiled-coil domain-containing protein 1,19425,1849,1.06 [1.02-1.11],0.0052382452324267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,21834,2088,1.26 [1.22-1.30],5.5598353019533785e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18582,1764,1.16 [1.06-1.27],0.0010086036510211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22222,2129,1.47 [1.32-1.64],2.8073218207653983e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,22606,2166,2.61 [2.45-2.77],1.5278748521188357e-210
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,22331,2138,1.26 [1.13-1.40],2.607454408461636e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,21826,2083,1.45 [1.32-1.59],3.537459055338049e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFER,FAD-linked sulfhydryl oxidase ALR,21834,2088,1.16 [1.09-1.24],1.3300498950108664e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,22470,2148,2.12 [1.87-2.40],2.6542050921389465e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRAL,GDNF family receptor alpha-like,18834,1792,0.85 [0.79-0.92],4.599141100421652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,22001,2096,1.59 [1.43-1.76],5.911745218899675e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,22323,2146,1.71 [1.61-1.82],2.212574139069837e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,22137,2130,2.30 [1.98-2.67],3.642191816268881e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH2,Growth hormone variant,21834,2088,0.97 [0.95-1.00],0.0243328147059167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,19045,1813,1.84 [1.56-2.17],4.165668820726265e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,22331,2138,0.87 [0.83-0.91],5.19093901386912e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GID8,Glucose-induced degradation protein 8 homolog,19419,1844,0.86 [0.74-0.99],0.0421512609897902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIGYF2,GRB10-interacting GYF protein 2,19419,1844,1.09 [1.03-1.16],0.0043171846648332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,19045,1813,0.66 [0.57-0.78],2.89648964285557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,18968,1809,1.17 [1.09-1.26],2.8728650539318195e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,19425,1849,1.58 [1.38-1.80],1.83444537787604e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,19017,1812,2.06 [1.85-2.30],2.740516569839429e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,22137,2130,1.49 [1.36-1.63],2.1002274290319616e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLO1,Lactoylglutathione lyase,21913,2105,1.14 [1.07-1.22],5.612160798399875e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,19045,1813,0.88 [0.77-0.99],0.0389783148817645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,22509,2156,2.28 [2.02-2.57],1.0673565833756448e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22279,2137,1.05 [1.01-1.09],0.018742674163523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOT1,"Aspartate aminotransferase, cytoplasmic",19475,1856,1.23 [1.12-1.35],2.896827426371331e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BA,Platelet glycoprotein Ib alpha chain,22266,2131,0.83 [0.74-0.94],0.0022942750660187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21633,2081,1.05 [1.00-1.10],0.0308123828457714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,22222,2129,0.93 [0.91-0.96],6.977327848677572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,22508,2152,1.23 [1.08-1.39],0.0016872237471747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,22137,2130,0.87 [0.81-0.93],6.65253947449414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,19371,1841,1.73 [1.61-1.85],1.143933891953241e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPHA2,Glycoprotein hormone alpha-2,19369,1846,0.84 [0.76-0.94],0.0024089973438366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPI,Glucose-6-phosphate isomerase,19470,1855,1.22 [1.11-1.34],2.9229901685792103e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19369,1846,0.90 [0.85-0.95],0.0003372179967757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPKOW,G-patch domain and KOW motifs-containing protein,21826,2083,1.26 [1.13-1.40],2.4192836770023644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,21720,2086,1.80 [1.58-2.06],6.114289633933672e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR101,Probable G-protein coupled receptor 101,18824,1792,0.90 [0.83-0.98],0.0188985293536129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR158,Probable G-protein coupled receptor 158,19419,1844,0.76 [0.66-0.87],0.0001071838693784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,21913,2105,1.37 [1.30-1.45],2.3999523815522783e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,19371,1841,1.47 [1.38-1.57],1.081421097750548e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19462,1849,1.22 [1.13-1.31],5.7849393234426824e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,22250,2139,1.64 [1.40-1.91],3.0618397702627605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",22222,2129,1.36 [1.28-1.44],6.4992322402095876e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,19405,1851,0.42 [0.38-0.47],4.5101823170142245e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,22292,2135,1.40 [1.35-1.46],1.1767486803529809e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,21834,2088,1.36 [1.31-1.43],3.975440199836785e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTP1,Glutathione S-transferase P,21693,2073,0.94 [0.88-0.99],0.0286496804345177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19109,1826,0.93 [0.86-0.99],0.0338649072495959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,22448,2148,1.61 [1.52-1.70],6.002743516075048e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMA,Granzyme A,22551,2158,1.35 [1.21-1.50],2.7863993361512605e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMB,Granzyme B,22279,2137,0.92 [0.87-0.98],0.0118736994589258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,22508,2152,1.27 [1.24-1.31],1.0871901314711252e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",22355,2147,1.06 [1.01-1.11],0.0280097116329976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,22471,2151,1.64 [1.56-1.73],4.7398543563021155e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,22355,2147,1.55 [1.40-1.71],1.1963039005418069e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBEGF,Proheparin-binding EGF-like growth factor,22433,2147,1.08 [1.02-1.14],0.004677315595848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBQ1,Hemoglobin subunit theta-1,22508,2152,0.92 [0.86-0.98],0.0094317091051893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCLS1,Hematopoietic lineage cell-specific protein,22551,2158,1.08 [1.01-1.16],0.0349737650034783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDAC8,Histone deacetylase 8,18885,1799,0.92 [0.84-1.00],0.0444878595917394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,19425,1849,1.11 [1.04-1.19],0.0028817231944359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,19045,1813,3.03 [2.59-3.55],1.3592530181318376e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPACAM2,HEPACAM family member 2,19425,1849,0.86 [0.78-0.96],0.0066090679983053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,19462,1849,3.16 [2.65-3.78],6.210139908043511e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEXIM1,Protein HEXIM1,22279,2137,1.09 [1.04-1.15],0.000303910064949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,22551,2158,2.54 [2.31-2.79],3.643116487823316e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,19425,1849,1.16 [1.10-1.23],6.195511316614734e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,19379,1843,1.41 [1.31-1.51],2.5215255749064934e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,19419,1844,1.33 [1.23-1.44],2.5058609900929205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22217,2131,1.33 [1.20-1.47],3.3218736558274674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22279,2137,1.20 [1.06-1.36],0.0047219007922825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,19016,1812,1.30 [1.20-1.41],1.9893994443304607e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,22079,2121,0.83 [0.77-0.90],1.3555217213063149e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX2,Heme oxygenase 2,21826,2083,1.11 [1.02-1.20],0.0143992257249291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,22033,2127,1.31 [1.21-1.41],1.3907043229500209e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,21851,2100,1.05 [1.00-1.11],0.0468977461354993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19419,1844,1.12 [1.02-1.22],0.0128483282958095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,21834,2088,0.76 [0.69-0.85],6.380159051393502e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPSE,Heparanase,19209,1831,1.07 [1.02-1.12],0.0062190557572928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,18968,1809,0.75 [0.65-0.87],0.0001247920809211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,19380,1838,1.40 [1.22-1.62],2.494195750546756e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22222,2129,1.21 [1.10-1.34],0.0001852921032326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22508,2152,1.14 [1.02-1.26],0.0207485745019445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,18885,1799,1.31 [1.16-1.48],2.041046313602497e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22279,2137,0.48 [0.44-0.53],1.0117702692646106e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19425,1849,1.32 [1.23-1.42],3.4305666498609773e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA1A,Heat shock 70 kDa protein 1A,22400,2149,1.08 [1.02-1.14],0.0060064258645067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,19371,1841,1.15 [1.02-1.30],0.0264370867908889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB1,Heat shock protein beta-1,21998,2106,1.07 [1.01-1.13],0.0251554324220187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,22508,2152,1.30 [1.19-1.43],3.622056016122702e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTR1B,5-hydroxytryptamine receptor 1B,18824,1792,0.89 [0.79-0.99],0.0374253235097979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,22246,2122,2.34 [2.02-2.71],5.007810133871753e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYOU1,Hypoxia up-regulated protein 1,22606,2166,0.83 [0.70-0.97],0.0214451877132755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,22263,2126,2.01 [1.78-2.26],7.096586408046512e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,22279,2137,0.74 [0.69-0.80],8.195371156367469e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,22331,2138,1.21 [1.11-1.31],6.406548014404559e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21826,2083,1.10 [1.02-1.19],0.0166516804433814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDO1,"Indoleamine 2,3-dioxygenase 1",18968,1809,1.10 [1.03-1.18],0.0079064372570272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDS,Iduronate 2-sulfatase,22551,2158,0.45 [0.30-0.67],0.0001027465611884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,22508,2152,1.68 [1.54-1.83],7.295342391736544e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18888,1807,1.62 [1.46-1.80],3.1952711716492724e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,22137,2130,1.44 [1.34-1.54],5.5221008292688e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,21826,2083,1.15 [1.06-1.25],0.001050275162896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNLR1,Interferon lambda receptor 1,22279,2137,1.27 [1.15-1.40],1.9073058406427664e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19475,1856,0.71 [0.60-0.84],4.344972213906915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,22222,2129,1.26 [1.06-1.50],0.0092401516165771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,22355,2147,2.52 [2.14-2.96],7.531491655931617e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,22571,2164,0.78 [0.75-0.80],4.8962653167978466e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,22580,2163,0.65 [0.61-0.69],8.162827339877657e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,22460,2144,0.83 [0.74-0.93],0.0012063028261511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,22065,2124,1.41 [1.31-1.52],1.7495640098116314e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,22606,2166,1.68 [1.52-1.85],7.605966000228501e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22331,2138,1.74 [1.57-1.92],8.617607782395714e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,19458,1849,1.34 [1.16-1.54],5.529030742417698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,22222,2129,2.15 [2.02-2.30],2.9867389978477673e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,22331,2138,1.92 [1.71-2.15],5.38507798470089e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,19462,1849,1.73 [1.65-1.81],4.245703091359604e-108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKBKG,NF-kappa-B essential modulator,22279,2137,1.07 [1.02-1.11],0.00357146929282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,21900,2081,1.07 [1.03-1.12],0.002035484555275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,22429,2152,1.81 [1.63-2.02],2.8004794644704797e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,22222,2129,1.17 [1.12-1.23],3.1390114031288516e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,22551,2158,1.26 [1.18-1.35],1.5502458681164722e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,21900,2081,1.43 [1.30-1.57],1.1131502942867628e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,22080,2117,1.52 [1.28-1.80],1.680729982412749e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,22279,2137,1.19 [1.06-1.34],0.0027816689104419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,21900,2081,1.16 [1.04-1.30],0.0060358524545406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL16,Pro-interleukin-16,22551,2158,1.17 [1.07-1.27],0.000521205139135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17A,Interleukin-17A,21867,2076,1.15 [1.06-1.26],0.0010203819762888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,21900,2081,1.18 [1.13-1.24],3.0211746623125564e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RA,Interleukin-17 receptor A,22355,2147,1.16 [1.06-1.26],0.0007224908773184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,22011,2118,0.70 [0.65-0.75],2.850622227717819e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,22257,2134,1.40 [1.30-1.52],1.3474946478912184e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,22460,2144,1.60 [1.43-1.79],1.3775122710656062e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,22551,2158,3.25 [2.93-3.61],3.486545625362885e-107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,21762,2095,1.17 [1.11-1.23],9.484189189954374e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,22323,2146,2.56 [2.18-2.99],9.554712253575267e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,22289,2134,3.60 [2.97-4.37],1.926586628601767e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RAP,Interleukin-1 receptor accessory protein,22355,2147,0.88 [0.81-0.96],0.00464834150339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,22541,2159,1.38 [1.26-1.50],1.8770948274812665e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL2,Interleukin-1 receptor-like 2,21900,2081,1.18 [1.06-1.31],0.0018872803819443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,22293,2140,1.64 [1.55-1.73],2.2976998691352666e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL21R,Interleukin-21 receptor,18885,1799,0.91 [0.84-0.99],0.0304056972745395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22,Interleukin-22,19371,1841,1.12 [1.06-1.20],0.0001441644267825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,22157,2121,1.21 [1.11-1.33],2.0536538104011783e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31RA,Interleukin-31 receptor subunit alpha,18807,1791,1.14 [1.01-1.28],0.036824328721379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,21900,2081,1.15 [1.02-1.30],0.01959907300116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,22279,2137,1.32 [1.20-1.46],2.7248442925500063e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5,Interleukin-5,21900,2081,0.97 [0.94-0.99],0.017358374039478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,22279,2137,1.14 [1.07-1.22],4.948279248174381e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,22222,2129,1.21 [1.16-1.26],3.2335860123218934e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,22331,2138,2.42 [1.97-2.98],7.968136457206268e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7R,Interleukin-7 receptor subunit alpha,22355,2147,0.81 [0.76-0.87],1.6512966900776347e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,21788,2078,1.07 [1.01-1.15],0.0344728422904685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,19371,1841,1.52 [1.40-1.65],7.59116734618077e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,19045,1813,1.10 [1.01-1.20],0.0211852902285986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,22355,2147,2.01 [1.82-2.23],1.2106348053736052e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",18968,1809,1.17 [1.08-1.26],0.0001474239504212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22222,2129,1.05 [1.01-1.10],0.011576425432286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,19425,1849,0.85 [0.81-0.90],2.329039108673447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,19369,1846,1.16 [1.11-1.21],1.2696681965337392e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,18885,1799,1.39 [1.08-1.80],0.0109281308299192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,22101,2129,1.08 [1.03-1.12],0.0010665424171019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22222,2129,1.20 [1.12-1.28],3.7999281322183093e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK4,Interleukin-1 receptor-associated kinase 4,22279,2137,1.05 [1.01-1.09],0.0193848416049966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,22279,2137,0.64 [0.58-0.72],1.4514914853133194e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,19045,1813,0.80 [0.70-0.91],0.0006688649116464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,22355,2147,2.69 [2.33-3.11],2.582881030258715e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,18885,1799,1.27 [1.14-1.42],1.2671638969700833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAM,Integrin alpha-M,22355,2147,1.41 [1.25-1.59],1.8024157212299243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,22508,2152,0.33 [0.26-0.41],8.304528064055987e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,22213,2137,1.78 [1.56-2.04],8.953855068881393e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,21900,2081,1.41 [1.24-1.60],1.659394003479873e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,22508,2152,1.17 [1.08-1.27],0.0001760932270813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,19475,1856,1.88 [1.71-2.07],5.330853204126108e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",18968,1809,1.08 [1.01-1.15],0.0227680325153005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,22509,2156,1.20 [1.05-1.38],0.0081924503890694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,19045,1813,1.11 [1.02-1.22],0.0175532029678943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JUN,Transcription factor AP-1,21900,2081,1.12 [1.03-1.20],0.0054069421786234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCTD5,BTB/POZ domain-containing protein KCTD5,19069,1809,1.28 [1.17-1.40],9.728542089649753e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDR,Vascular endothelial growth factor receptor 2,22422,2149,1.20 [1.03-1.40],0.0222263864180633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KEL,Kell blood group glycoprotein,21826,2083,1.15 [1.03-1.28],0.0094585569163912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,18968,1809,1.58 [1.47-1.69],1.4936162617791676e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA0319,Dyslexia-associated protein KIAA0319,19425,1849,0.62 [0.53-0.72],1.0242030945322615e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF1C,Kinesin-like protein KIF1C,18799,1796,1.17 [1.04-1.33],0.0105363888752896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF22,Kinesin-like protein KIF22,18799,1796,1.09 [1.05-1.13],5.14145028932963e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIFBP,KIF-binding protein,22222,2129,1.06 [1.01-1.11],0.0231966721954235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19369,1846,0.97 [0.94-0.99],0.0076199263884331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL2,Kin of IRRE-like protein 2,21826,2083,0.83 [0.75-0.92],0.0001965863711031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,22412,2141,0.66 [0.58-0.75],7.838045903100903e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,22331,2138,0.70 [0.63-0.77],5.630362849602269e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,21826,2083,0.92 [0.87-0.97],0.0027930764982409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK10,Kallikrein-10,22355,2143,0.86 [0.78-0.94],0.0016543466524096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK13,Kallikrein-13,21847,2091,0.92 [0.85-1.00],0.0454050669233846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,22508,2152,0.77 [0.71-0.84],6.97562665811113e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,19475,1856,0.95 [0.91-0.99],0.024355298683168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,22508,2152,1.20 [1.13-1.27],4.96449362128392e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,18563,1766,0.77 [0.68-0.87],2.4748251187364106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22551,2158,1.76 [1.61-1.93],3.6168110183317694e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,22551,2158,1.23 [1.14-1.33],3.463660474341016e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,18885,1799,1.23 [1.14-1.33],2.783577285148324e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,19425,1849,1.16 [1.06-1.27],0.0018185368537601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",22222,2129,1.45 [1.39-1.50],6.255451813935092e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",22234,2132,1.33 [1.26-1.40],1.0756745683474683e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT5,"Keratin, type II cytoskeletal 5",21826,2083,0.87 [0.80-0.94],0.0004723671559955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",18824,1792,1.30 [1.26-1.35],2.818231667872809e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,22551,2158,1.61 [1.49-1.74],1.1374037825005768e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19462,1849,1.07 [1.02-1.13],0.0058764073635191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,22222,2129,1.31 [1.19-1.43],7.757586460002836e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22325,2139,1.34 [1.23-1.45],4.5000321958971396e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,18968,1809,2.25 [1.94-2.62],5.448791922247054e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,18913,1805,1.37 [1.26-1.50],2.351345343531749e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,21651,2089,2.49 [2.05-3.03],7.554035564583371e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP3,Lysosome-associated membrane glycoprotein 3,22519,2155,1.09 [1.02-1.17],0.014396759836436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMTOR5,Ragulator complex protein LAMTOR5,19371,1841,0.88 [0.78-0.98],0.0267919795426821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAP3,Cytosol aminopeptidase,21900,2081,1.17 [1.09-1.27],3.157823005986243e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT,Linker for activation of T-cells family member 1,22551,2158,1.10 [1.05-1.16],0.0001990472114008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT2,Linker for activation of T-cells family member 2,22222,2129,1.05 [1.02-1.09],0.0008974505393397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LATS1,Serine/threonine-protein kinase LATS1,18885,1799,1.08 [1.03-1.14],0.0042104649728042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,22104,2129,1.35 [1.22-1.50],4.88701024742878e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,22460,2144,1.26 [1.18-1.35],2.2137945645904888e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,22509,2156,1.16 [1.11-1.22],3.7865532382059986e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCAT,Phosphatidylcholine-sterol acyltransferase,19470,1855,1.96 [1.58-2.42],6.33909033472079e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,19419,1844,1.15 [1.08-1.23],7.231939185987381e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,21710,2067,1.14 [1.04-1.26],0.0054718536992458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCP1,Plastin-2,19475,1856,0.90 [0.82-0.99],0.029223002621299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,22388,2146,1.28 [1.19-1.38],1.5360543945723823e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LECT2,Leukocyte cell-derived chemotaxin-2,19462,1849,1.15 [1.08-1.23],2.77888847846366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEO1,RNA polymerase-associated protein LEO1,19419,1844,1.18 [1.05-1.33],0.0057702685895948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,22331,2138,1.29 [1.22-1.37],1.0451271760194295e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEPR,Leptin receptor,22331,2138,0.82 [0.72-0.93],0.0016477207031811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,19419,1844,1.20 [1.11-1.30],6.646594816513811e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,22331,2138,1.15 [1.03-1.28],0.0134786501063521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,19494,1852,1.76 [1.59-1.95],3.357197304722875e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,22325,2139,2.15 [2.02-2.28],1.3201958035782013e-140
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS7_LGALS7B,Galectin-7,22238,2125,0.86 [0.78-0.94],0.0009057084110403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,22326,2143,1.66 [1.48-1.87],3.9436370032191495e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,22429,2152,1.41 [1.27-1.57],1.1779050000325828e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIF,Leukemia inhibitory factor,21826,2083,1.13 [1.06-1.22],0.0005225841989868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,22279,2137,2.49 [2.17-2.87],1.0418908182452585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22355,2147,1.26 [1.13-1.40],2.416077540821776e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22288,2136,1.49 [1.32-1.67],3.3407143343771386e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22606,2166,1.51 [1.31-1.73],5.8005156300285815e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22515,2156,1.32 [1.18-1.48],9.391261052520434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,21900,2081,1.27 [1.17-1.39],1.8880158771774032e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,18968,1809,1.19 [1.11-1.28],1.6177283608474234e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB2,Lamin-B2,19425,1849,1.21 [1.04-1.41],0.0164347515845207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD1,Leiomodin-1,19419,1844,0.86 [0.75-0.99],0.0344721141500711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LONP1,"Lon protease homolog, mitochondrial",18968,1809,1.12 [1.06-1.18],3.5771989316079207e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22222,2129,1.12 [1.03-1.21],0.005015763863853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,22331,2138,0.53 [0.50-0.56],8.706292513546481e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,21567,2077,1.41 [1.33-1.50],7.779484967157695e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,18799,1796,1.16 [1.09-1.24],5.148699314974521e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22433,2147,1.17 [1.05-1.30],0.0042537915171894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18820,1794,1.49 [1.30-1.71],2.09544405252806e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,22222,2129,0.84 [0.72-0.97],0.0178028368088528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,22331,2138,1.36 [1.23-1.50],3.191950659480584e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC25,Leucine-rich repeat-containing protein 25,22222,2129,1.14 [1.04-1.26],0.0072387644342171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC59,Leucine-rich repeat-containing protein 59,19462,1849,1.11 [1.02-1.22],0.0215570741500642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19371,1841,1.13 [1.03-1.24],0.0103338755161815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,21900,2081,0.86 [0.78-0.95],0.0034830464514421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19419,1844,0.66 [0.55-0.79],7.903608830897942e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSP1,Lymphocyte-specific protein 1,22279,2137,1.31 [1.19-1.43],1.6203062594437382e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA,Lymphotoxin-alpha,22279,2137,1.11 [1.01-1.22],0.0272901315420191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,21834,2088,1.24 [1.16-1.32],2.2007180984359568e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,22231,2129,1.19 [1.05-1.35],0.0069021186099601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,22228,2136,0.88 [0.80-0.97],0.0117927417807573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,22036,2108,1.31 [1.16-1.49],2.4404225258363817e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,22137,2130,1.33 [1.20-1.48],3.917502656789783e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYN,Tyrosine-protein kinase Lyn,22222,2129,1.07 [1.02-1.12],0.0055941186377174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,22237,2131,1.40 [1.25-1.56],3.1980706509926843e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,21834,2088,1.13 [1.05-1.21],0.0006206207892275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19494,1852,1.33 [1.07-1.67],0.0118697632460498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,M6PR,Cation-dependent mannose-6-phosphate receptor,18968,1809,1.15 [1.03-1.28],0.0115459374809206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22062,2125,1.25 [1.18-1.34],1.0361363874862017e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,19462,1849,1.20 [1.06-1.35],0.0036668878130909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,19371,1841,1.49 [1.38-1.61],1.9493000285895288e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,19462,1849,1.34 [1.24-1.44],2.507900792778184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2,Microtubule-associated protein 2,19425,1849,1.18 [1.08-1.29],0.000318323841538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK13,Mitogen-activated protein kinase 13,18754,1788,1.12 [1.01-1.24],0.0369282537502405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARCO,Macrophage receptor MARCO,22331,2138,1.62 [1.40-1.87],8.09838083659045e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,22104,2129,1.88 [1.60-2.22],5.5943770962031565e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN2,Matrilin-2,22359,2146,1.16 [1.02-1.32],0.0260455775031904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,22101,2129,0.45 [0.40-0.51],3.799127232615431e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAX,Protein max,21826,2083,1.04 [1.00-1.08],0.0416222619873694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,22606,2166,1.10 [1.03-1.18],0.0048586525793743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCAM,Cell surface glycoprotein MUC18,22460,2144,0.67 [0.60-0.75],1.5637808680094288e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCFD2,Multiple coagulation factor deficiency protein 2,22217,2128,1.11 [1.01-1.21],0.0234830494226908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22137,2130,1.16 [1.09-1.22],2.640216718970869e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,22359,2143,1.20 [1.12-1.28],2.086007198671209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDM1,Nuclear protein MDM1,18933,1813,0.81 [0.70-0.94],0.0065877150250791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",18968,1809,1.08 [1.02-1.13],0.0037552823586578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,22325,2139,0.87 [0.78-0.96],0.0053929278347398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,22541,2159,1.77 [1.46-2.16],8.333381650480166e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,19045,1813,0.32 [0.27-0.39],2.6029016896896767e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,19369,1846,1.31 [1.24-1.39],2.8593967404640867e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,22325,2139,0.63 [0.55-0.72],7.017242783842259e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,22551,2158,1.30 [1.12-1.50],0.0006012878479066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,22385,2148,0.32 [0.27-0.39],7.981111607551358e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22279,2137,1.06 [1.01-1.11],0.0151750944321309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP2,Methionine aminopeptidase 2,22470,2148,1.09 [1.02-1.17],0.0129400655187224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,19045,1813,1.94 [1.69-2.22],7.369240467707674e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP5,Microfibrillar-associated protein 5,22606,2166,1.11 [1.01-1.21],0.0354204473095044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,22355,2147,1.95 [1.80-2.12],2.609635835330313e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIA,Melanoma-derived growth regulatory protein,22422,2149,0.84 [0.75-0.93],0.0011095755031212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22279,2137,1.06 [1.03-1.09],2.7060330048054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIF,Macrophage migration inhibitory factor,22319,2142,1.06 [1.00-1.13],0.0373556127895772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,21900,2081,1.22 [1.13-1.31],2.5307563004404854e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINK1,Misshapen-like kinase 1,19425,1849,1.06 [1.01-1.11],0.022746591040619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,22279,2137,1.13 [1.08-1.18],8.610525186662839e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,22222,2129,1.42 [1.36-1.49],5.654469136583372e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,21511,2068,1.07 [1.02-1.12],0.0031144445106174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,22269,2137,1.17 [1.10-1.25],8.157661931649337e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,22328,2141,1.50 [1.40-1.60],9.326399945173164e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP13,Collagenase 3,21826,2083,0.76 [0.68-0.86],9.836585419513088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP3,Stromelysin-1,22355,2147,0.92 [0.85-0.99],0.0241184263796025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,21879,2102,1.54 [1.41-1.67],1.3801900361899268e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,22468,2154,1.16 [1.10-1.22],2.3061636454319943e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,22310,2143,1.24 [1.16-1.32],7.385428438828844e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNDA,Myeloid cell nuclear differentiation antigen,22292,2135,1.05 [1.01-1.09],0.0115670260221224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOCS2,Molybdopterin synthase catalytic subunit,19045,1813,1.08 [1.01-1.16],0.023397542863166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOG,Myelin-oligodendrocyte glycoprotein,22508,2152,0.85 [0.76-0.95],0.0049249722031692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPO,Myeloperoxidase,22355,2147,1.21 [1.12-1.31],7.860640423290596e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,19470,1855,1.83 [1.58-2.12],1.1999396096790926e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL46,"39S ribosomal protein L46, mitochondrial",21826,2083,1.21 [1.06-1.37],0.0045062644159758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL52,"39S ribosomal protein L52, mitochondrial",18711,1782,0.81 [0.68-0.97],0.0242890799401711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19419,1844,1.07 [1.01-1.13],0.0270098831666358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,22509,2156,1.69 [1.56-1.84],2.9020470616340423e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSTN,Growth/differentiation factor 8,21913,2105,1.08 [1.01-1.16],0.0347552012788284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTDH,Protein LYRIC,18885,1799,1.10 [1.05-1.16],0.0001003648268878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19109,1826,1.05 [1.01-1.09],0.014280017153418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS1,Protein MTSS 1,19369,1846,1.07 [1.03-1.11],0.0008377534308937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,19109,1826,1.39 [1.30-1.49],1.0710684358038036e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,21826,2083,2.05 [1.92-2.19],3.9100988665297524e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC2,Mucin-2,19475,1856,1.10 [1.05-1.15],8.379549340442046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,21900,2081,1.46 [1.39-1.52],2.360187931989472e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,19045,1813,0.28 [0.25-0.32],2.3656490486107577e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",19462,1849,1.13 [1.07-1.20],2.722571402361096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",18968,1809,1.06 [1.01-1.12],0.0189878205306302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYDGF,Myeloid-derived growth factor,19462,1849,1.08 [1.03-1.13],0.0007962518027044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH9,Myosin-9,19475,1856,1.05 [1.01-1.09],0.0130248123552976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL3,Myosin light chain 3,18968,1809,1.10 [1.04-1.17],0.0015405568646106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL4,Myosin light chain 4,18968,1809,1.10 [1.02-1.19],0.015851158807145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",18933,1813,1.14 [1.05-1.23],0.0025562661893523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,22355,2147,0.76 [0.70-0.83],1.8317876107761152e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZB1,Marginal zone B- and B1-cell-specific protein,22397,2148,1.22 [1.13-1.31],7.52549397658873e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22042,2123,0.91 [0.85-0.97],0.0035078864303008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NADK,NAD kinase,22331,2138,1.16 [1.09-1.24],2.3212092530897413e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGA,Alpha-N-acetylgalactosaminidase,18840,1793,1.09 [1.01-1.18],0.029217353897301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19045,1813,2.64 [2.16-3.22],1.3070736510111756e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAMPT,Nicotinamide phosphoribosyltransferase,21834,2088,1.15 [1.07-1.22],2.8456194085388352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22422,2149,1.47 [1.28-1.69],4.336720037912753e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBN,Nibrin,21900,2081,1.07 [1.00-1.15],0.0413534829014077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM1,Neural cell adhesion molecule 1,22460,2144,0.81 [0.72-0.92],0.0011057527006223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM2,Neural cell adhesion molecule 2,22355,2147,0.71 [0.62-0.82],4.198059435618243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,22509,2156,0.59 [0.53-0.65],2.0971644786579635e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCF2,Neutrophil cytosol factor 2,22247,2133,1.07 [1.02-1.11],0.003609788095316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,22245,2135,1.25 [1.14-1.38],6.989415386853471e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19369,1846,1.20 [1.06-1.37],0.004168864539041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,22508,2152,1.57 [1.37-1.78],1.9154104121485367e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19371,1841,0.87 [0.81-0.94],0.0007231793196698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",21834,2088,1.08 [1.03-1.13],0.0011049660479138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,22288,2136,1.83 [1.63-2.06],1.9292383457115475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,22422,2149,1.16 [1.04-1.29],0.0101530959759802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,21759,2077,1.25 [1.15-1.36],1.065926038778978e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,22422,2149,0.74 [0.68-0.81],2.2438374399307424e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL2,Protein kinase C-binding protein NELL2,22429,2152,1.24 [1.09-1.41],0.0011668479121123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,22551,2158,5.32 [4.74-5.97],9.774608329959894e-177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22279,2137,1.05 [1.01-1.09],0.0198009196118806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",21900,2081,1.30 [1.22-1.38],3.600000899455725e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFE2,Transcription factor NF-E2 45 kDa subunit,18968,1809,1.10 [1.03-1.17],0.0022956976102763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,18799,1796,1.07 [1.00-1.14],0.0381203391458559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKBIE,NF-kappa-B inhibitor epsilon,21834,2088,1.12 [1.03-1.21],0.0063558891647555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFX1,Transcriptional repressor NF-X1,18799,1796,1.10 [1.03-1.18],0.0046899111323241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,19425,1849,1.35 [1.13-1.61],0.0008629918046175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,18562,1765,2.87 [2.48-3.32],3.60621637193202e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID1,Nidogen-1,22375,2141,1.14 [1.03-1.26],0.0109777462120799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID2,Nidogen-2,22355,2147,1.06 [1.01-1.12],0.0198476194677862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT2,Omega-amidase NIT2,19389,1838,1.20 [1.13-1.27],1.2796111258675304e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,22359,2146,0.51 [0.43-0.61],5.51619340106559e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22137,2130,1.11 [1.06-1.16],2.0680099259403e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,22355,2147,2.15 [1.83-2.53],1.232761968135756e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",21826,2083,1.14 [1.06-1.22],0.0002716860572105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",21826,2083,1.36 [1.28-1.43],3.750414966090548e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,22606,2166,1.68 [1.32-2.12],1.7358735740186733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH2,Neurogenic locus notch homolog protein 2,19475,1856,0.71 [0.58-0.88],0.0014349323933703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,22606,2166,0.60 [0.53-0.67],1.5678624523888404e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,19133,1823,1.64 [1.46-1.83],2.7037711918682933e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,22331,2138,1.28 [1.15-1.43],7.204846950087495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,19462,1849,1.37 [1.25-1.50],2.942110163018074e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPC,C-type natriuretic peptide,22279,2137,1.20 [1.11-1.28],6.334306685835735e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,22355,2147,1.22 [1.11-1.34],2.9051910126883865e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTXR,Neuronal pentraxin receptor,22331,2138,0.87 [0.78-0.97],0.0131578517430025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,22508,2152,1.54 [1.44-1.64],1.914160353908064e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,22331,2138,2.13 [1.91-2.38],1.3783985392712415e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,22487,2145,1.96 [1.72-2.24],1.4851944157363742e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRXN3,Neurexin-3,18933,1813,0.85 [0.74-0.98],0.022043871752749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,19425,1849,1.31 [1.17-1.48],3.819177177188525e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,22422,2149,1.27 [1.19-1.36],3.251019492671493e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,22279,2137,1.24 [1.12-1.37],3.8876372201906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK2,BDNF/NT-3 growth factors receptor,22331,2138,1.48 [1.27-1.71],3.368746683745671e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,22509,2156,0.39 [0.33-0.46],1.1327578014203371e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,22464,2150,1.20 [1.08-1.33],0.0006494312033823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDC,Nuclear migration protein nudC,22551,2158,1.08 [1.01-1.15],0.0150060061146659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22222,2129,0.91 [0.84-0.97],0.0057977023533915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT5,ADP-sugar pyrophosphatase,22355,2147,1.17 [1.08-1.26],5.660738165279416e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUMB,Protein numb homolog,18885,1799,1.09 [1.03-1.16],0.0018750614299218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH3,Neurexophilin-3,18885,1799,0.74 [0.64-0.86],9.655903817120824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,22070,2127,0.84 [0.79-0.89],3.4183200106305626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,19419,1844,1.67 [1.53-1.83],3.992444698392741e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ODAM,Odontogenic ameloblast-associated protein,21793,2079,0.88 [0.82-0.94],0.0004727124428488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,22355,2147,1.14 [1.04-1.24],0.0041271250180161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,18329,1742,1.16 [1.12-1.21],9.805529546701749e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLR1,Oxidized low-density lipoprotein receptor 1,22110,2116,1.13 [1.06-1.20],0.0002090190917648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,22429,2152,0.58 [0.53-0.63],2.3062428080599715e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,22222,2129,0.88 [0.83-0.93],1.2096553705140822e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPLAH,5-oxoprolinase,18968,1809,1.10 [1.02-1.17],0.0083853461535529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,22222,2129,0.73 [0.66-0.80],1.0533946949466926e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22359,2146,1.18 [1.06-1.32],0.0027633952859155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,22182,2127,1.28 [1.21-1.35],1.3129252255676377e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,22487,2145,1.62 [1.34-1.96],4.546800483143624e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD7B,OTU domain-containing protein 7B,19419,1844,1.08 [1.00-1.16],0.048756554755422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,22509,2156,1.16 [1.13-1.19],2.9096977234787075e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,22241,2130,1.38 [1.25-1.53],1.0921731952642684e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI2,Protein-arginine deiminase type-2,21900,2081,1.10 [1.04-1.17],0.0022471250190048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI4,Protein-arginine deiminase type-4,21793,2079,1.06 [1.01-1.11],0.0168005967833802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,21913,2105,1.34 [1.26-1.43],1.0416461355250013e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAK4,Serine/threonine-protein kinase PAK 4,21826,2083,1.08 [1.01-1.15],0.0201498991127209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,19425,1849,1.87 [1.70-2.07],2.0555868563050984e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22504,2160,0.81 [0.71-0.93],0.0020783507651611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,22355,2147,2.37 [2.06-2.73],4.052643671145382e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAPPA,Pappalysin-1,21900,2081,0.90 [0.83-0.98],0.0185060143025217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARP1,Poly [ADP-ribose] polymerase 1,22279,2137,1.11 [1.05-1.18],0.0003507297370433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAXX,Protein PAXX,19045,1813,1.12 [1.02-1.24],0.0204993780008726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,21826,2083,1.33 [1.24-1.42],6.9798900296768665e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19016,1811,1.80 [1.67-1.95],1.062648327589969e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,22478,2148,1.31 [1.11-1.55],0.0013995796767121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH12,Protocadherin-12,19419,1844,1.24 [1.04-1.47],0.0157225694416722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,22331,2138,1.77 [1.62-1.94],2.2790615735665188e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH9,Protocadherin-9,19369,1846,1.49 [1.31-1.69],1.7625377821586583e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,22606,2166,1.88 [1.71-2.07],6.623621319131032e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19369,1846,1.15 [1.09-1.22],2.7277861674289166e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,22468,2149,1.21 [1.12-1.32],4.278762046279406e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,22222,2129,1.46 [1.31-1.64],4.254700130348681e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFC,Platelet-derived growth factor C,21834,2088,1.30 [1.14-1.49],0.0001087274591905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,22331,2138,1.42 [1.24-1.62],2.769204749004264e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA3,Protein disulfide-isomerase A3,19045,1813,1.32 [1.11-1.57],0.0015003920644666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM7,PDZ and LIM domain protein 7,22429,2152,1.03 [1.00-1.06],0.0487949866848361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18885,1799,1.87 [1.73-2.02],2.0040486409968368e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEBP1,Phosphatidylethanolamine-binding protein 1,22355,2147,1.08 [1.01-1.16],0.0172114282168979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECAM1,Platelet endothelial cell adhesion molecule,22355,2147,1.30 [1.15-1.47],3.265103825421755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,19470,1855,0.64 [0.54-0.76],3.811322764797125e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PF4,Platelet factor 4,19346,1838,1.07 [1.02-1.12],0.0056909789874684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,19470,1855,1.12 [1.06-1.18],5.491693148941153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19462,1849,1.10 [1.01-1.20],0.0275609679394326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,22551,2158,1.78 [1.56-2.03],7.164298920737985e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22137,2130,1.16 [1.02-1.32],0.0261684628824405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19045,1813,1.30 [1.16-1.44],3.22546924582718e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI16,Peptidase inhibitor 16,19470,1855,0.68 [0.57-0.81],1.183842975575364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,22053,2110,1.13 [1.06-1.21],0.0001338680615531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19419,1844,1.08 [1.01-1.14],0.0137661690446348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,22057,2118,2.66 [2.41-2.93],9.280062292044038e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22355,2147,1.58 [1.40-1.78],2.2405476661191522e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22355,2147,1.52 [1.39-1.66],1.6521495660141026e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,22331,2138,1.33 [1.24-1.43],1.1028690626169584e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,19462,1849,1.95 [1.65-2.31],6.054294592726901e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD2,Polycystin-2,18799,1796,1.11 [1.03-1.20],0.0087496937178858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G10,Group 10 secretory phospholipase A2,22137,2130,1.07 [1.01-1.15],0.033839207560711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,22422,2149,2.39 [2.10-2.74],7.057874784064214e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,22575,2164,0.67 [0.62-0.73],3.123993026957495e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,22355,2147,0.42 [0.37-0.46],3.245029761728051e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,22541,2159,1.43 [1.33-1.54],6.644923262787542e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,22184,2127,2.08 [1.83-2.37],2.603310037060452e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",19425,1849,0.90 [0.83-0.97],0.0056473981746062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19425,1849,1.13 [1.06-1.20],0.0002068610055741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLG,Plasminogen,19008,1795,1.45 [1.17-1.79],0.0006387170174179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN1,Perilipin-1,21826,2083,1.28 [1.16-1.41],8.825425189616261e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,22331,2138,1.18 [1.08-1.29],0.0003167661053414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLSCR3,Phospholipid scramblase 3,19384,1842,1.18 [1.09-1.27],3.919027485330722e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,22547,2162,0.61 [0.55-0.67],4.504636097603101e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,19425,1849,1.42 [1.24-1.62],2.716516049878218e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNA4,Plexin-A4,22279,2137,1.08 [1.03-1.13],0.001076194053333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,22491,2153,5.60 [4.92-6.38],5.032456672348869e-148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB3,Plexin-B3,22271,2132,1.15 [1.06-1.24],0.0008681308213089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19425,1849,1.08 [1.02-1.14],0.0048309289837068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL,Podocalyxin,22222,2129,0.62 [0.48-0.80],0.0002022366362436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL2,Podocalyxin-like protein 2,22422,2149,0.70 [0.61-0.80],3.24995980404271e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,18885,1799,1.34 [1.23-1.46],1.1262339483381135e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22222,2129,1.16 [1.04-1.28],0.0058474021573888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,19470,1855,0.64 [0.56-0.73],1.7464711092921819e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON2,Serum paraoxonase/arylesterase 2,21913,2105,1.20 [1.08-1.34],0.0008013754102409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,22429,2152,0.60 [0.56-0.63],4.9115313037470185e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POSTN,Periostin,19475,1856,0.71 [0.63-0.80],1.4158990169140684e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPBP,Platelet basic protein,19357,1838,1.06 [1.01-1.12],0.0247359290609519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22422,2149,1.05 [1.01-1.10],0.0108099491145141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19419,1844,1.16 [1.04-1.29],0.007421298646862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R2,Protein phosphatase inhibitor 2,22331,2138,1.06 [1.01-1.11],0.0279691537394579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R9B,Neurabin-2,22551,2158,1.07 [1.03-1.12],0.0007733542517739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,22332,2139,1.11 [1.07-1.15],9.112189261192704e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,19475,1856,3.71 [3.29-4.19],7.187027792811635e-100
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,22482,2153,2.73 [2.53-2.95],4.4844784199273147e-150
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",21900,2081,1.12 [1.06-1.18],5.45582042048669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX6,Peroxiredoxin-6,22508,2152,0.92 [0.86-0.98],0.0080049279160298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,21900,2081,1.35 [1.21-1.51],1.3813200795421605e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG3,Proteoglycan 3,19475,1856,0.87 [0.79-0.95],0.0015224875890426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22331,2138,1.06 [1.01-1.11],0.0156620768361034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19390,1845,1.10 [1.04-1.16],0.001542439836918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,21834,2088,1.14 [1.08-1.20],7.733122230385165e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROC,Vitamin K-dependent protein C,22412,2141,1.30 [1.12-1.51],0.0007765964371918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROCR,Endothelial protein C receptor,18799,1796,0.83 [0.72-0.97],0.0170506793558568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROK1,Prokineticin-1,22279,2137,1.07 [1.00-1.15],0.0365795585410976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,19494,1852,1.27 [1.07-1.51],0.0069135614583252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRRT3,Proline-rich transmembrane protein 3,18968,1809,0.73 [0.65-0.82],1.572262176016854e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,18885,1799,1.15 [1.03-1.29],0.0132082127244753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,22268,2132,1.26 [1.14-1.38],1.784087473525983e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS53,Serine protease 53,19425,1849,0.88 [0.79-0.99],0.0381848321625024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,22248,2136,2.55 [2.34-2.77],1.6128788485599577e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,22508,2152,1.38 [1.18-1.61],4.851954368633512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRUNE2,Protein prune homolog 2,19109,1826,1.44 [1.26-1.64],4.5599312992689696e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,19279,1835,1.51 [1.32-1.72],8.74777207421511e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAPL1,Proactivator polypeptide-like 1,19369,1846,0.71 [0.65-0.78],5.90701137641777e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSIP1,PC4 and SFRS1-interacting protein,22279,2137,1.09 [1.03-1.16],0.001612183191889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME1,Proteasome activator complex subunit 1,22087,2128,1.16 [1.05-1.29],0.0041696089347005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME2,Proteasome activator complex subunit 2,22028,2121,1.18 [1.07-1.32],0.0016795623595554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG3,Proteasome assembly chaperone 3,22279,2137,1.09 [1.01-1.17],0.0189180533052338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSPN,Persephin,22279,2137,1.04 [1.00-1.09],0.0389636933491611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSRC1,Proline/serine-rich coiled-coil protein 1,21834,2088,1.13 [1.06-1.20],0.0001700030968226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,22185,2115,1.55 [1.39-1.73],7.769530912135458e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGES2,Prostaglandin E synthase 2,18746,1784,1.09 [1.00-1.19],0.0445778470588824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,19462,1849,1.38 [1.31-1.45],4.128597513243506e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22279,2137,1.25 [1.15-1.36],8.886492051707831e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,21826,2083,1.32 [1.19-1.46],6.872661323017906e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTN,Pleiotrophin,21913,2105,1.18 [1.09-1.28],2.0249309627249907e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,18885,1799,1.26 [1.17-1.36],8.578186039647641e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22137,2130,1.08 [1.02-1.13],0.0035321807513819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19462,1849,2.21 [1.90-2.56],1.348472894541299e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,19475,1856,1.57 [1.31-1.87],9.050801789678256e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,22606,2166,0.48 [0.42-0.54],7.749920126297264e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,19369,1846,1.29 [1.18-1.41],4.68699688691322e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19369,1846,1.70 [1.48-1.97],3.1438441735234734e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22249,2132,1.53 [1.31-1.79],1.0279170027433922e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,19425,1849,0.77 [0.68-0.87],3.793426858607437e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,22606,2166,0.47 [0.40-0.55],4.575026331196804e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21718,2071,1.59 [1.50-1.68],2.9036701707734284e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,22279,2137,1.13 [1.04-1.23],0.0026363977975671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,22509,2156,1.77 [1.61-1.94],3.74932598523314e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXN,Paxillin,21826,2083,1.13 [1.05-1.21],0.0010288227877574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYDC1,Pyrin domain-containing protein 1,18968,1809,0.76 [0.68-0.86],6.124568055141128e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,18799,1796,1.33 [1.27-1.39],2.073636293942409e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QDPR,Dihydropteridine reductase,22224,2130,1.30 [1.19-1.42],1.2481154182886472e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,22380,2140,1.58 [1.38-1.81],2.8078824718122398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,19114,1811,1.32 [1.23-1.43],3.6662459923488266e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB11FIP3,Rab11 family-interacting protein 3,19462,1849,1.04 [1.00-1.09],0.0468811838275561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB27B,Ras-related protein Rab-27B,19462,1849,1.10 [1.04-1.16],0.0009592878058088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB39B,Ras-related protein Rab-39B,18799,1796,1.06 [1.01-1.11],0.0091490749791119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB44,Ras-related protein Rab-44,19371,1841,1.14 [1.04-1.24],0.0048157169938484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,22279,2137,0.73 [0.67-0.80],9.068267591692309e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALY,RNA-binding protein Raly,19371,1841,1.09 [1.00-1.19],0.0450303425011555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,21834,2088,1.14 [1.02-1.27],0.0167907543520858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,22487,2145,1.41 [1.31-1.52],9.379607549187282e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASSF2,Ras association domain-containing protein 2,21834,2088,1.09 [1.03-1.16],0.0061257042462636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,19419,1844,1.49 [1.36-1.63],3.917566275706528e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBKS,Ribokinase,21802,2109,1.19 [1.11-1.29],3.532078190952808e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,22222,2129,1.16 [1.11-1.22],1.670496358313993e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,22222,2129,1.72 [1.62-1.82],4.0190526801211753e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,19369,1846,1.13 [1.06-1.22],0.0004067430473063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS2,RNA-binding protein with multiple splicing 2,18968,1809,1.07 [1.03-1.12],0.0017684864101652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCC1,Regulator of chromosome condensation,19371,1841,1.16 [1.07-1.26],0.0001689029303024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,22214,2122,1.46 [1.36-1.56],5.641352926011256e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,22606,2166,1.31 [1.23-1.39],6.464008246332779e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,22606,2166,1.14 [1.08-1.21],4.080998806447805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,22359,2146,1.69 [1.57-1.81],5.417873996228945e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,22355,2147,1.28 [1.13-1.45],0.0001217667561836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,22331,2138,1.47 [1.41-1.52],7.950412627820952e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22222,2129,2.25 [2.04-2.48],9.273357011594265e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,22290,2140,1.13 [1.04-1.23],0.0051150761384963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19109,1826,1.08 [1.02-1.16],0.0155807738193814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RHOC,Rho-related GTP-binding protein RhoC,22004,2123,1.03 [1.00-1.07],0.0487815804238226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19045,1813,1.62 [1.50-1.76],5.890201165631657e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,19470,1855,1.45 [1.25-1.68],1.2354165789668295e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE3,Eosinophil cationic protein,22229,2129,1.05 [1.01-1.08],0.0044724009290428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,18799,1784,1.77 [1.54-2.03],1.0665342359320968e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,19329,1843,1.46 [1.32-1.62],3.4271391473546373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,22511,2158,1.83 [1.62-2.08],2.99993762014086e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,18968,1809,1.48 [1.30-1.69],2.226417882009174e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF41,E3 ubiquitin-protein ligase NRDP1,21834,2088,1.09 [1.03-1.15],0.0050625858456938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,22359,2146,2.11 [1.83-2.43],7.171221178082226e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO2,Roundabout homolog 2,22509,2156,1.52 [1.30-1.78],2.325938732577849e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPL14,60S ribosomal protein L14,18968,1809,1.12 [1.01-1.25],0.0328761409402308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,21834,2088,1.15 [1.07-1.23],6.683708100277203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,21834,2088,1.07 [1.00-1.13],0.0346553224396796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO1,R-spondin-1,22137,2130,0.74 [0.66-0.83],2.1590147656369725e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,22508,2152,0.81 [0.70-0.92],0.0017086835950384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,22508,2152,2.67 [2.45-2.91],1.1728707298318153e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A11,Protein S100-A11,22162,2117,1.10 [1.02-1.19],0.0162329996882563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,19419,1844,0.84 [0.77-0.92],0.0001001689809281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,21913,2105,1.21 [1.14-1.29],1.102548172559854e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22279,2137,1.07 [1.01-1.12],0.0195707874005945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SARG,Specifically androgen-regulated gene protein,19375,1844,1.07 [1.02-1.11],0.0017053565962217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,18799,1796,1.14 [1.02-1.27],0.0195418231526264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,19109,1826,1.12 [1.05-1.20],0.0004128761697867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SBSN,Suprabasin,19437,1849,0.65 [0.57-0.74],5.966430790226243e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCAMP3,Secretory carrier-associated membrane protein 3,22222,2129,1.11 [1.06-1.16],7.277613973343342e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,22509,2156,1.84 [1.63-2.07],2.8192658919637176e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,21723,2089,1.56 [1.40-1.73],2.2241387900938293e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,22606,2166,1.16 [1.06-1.26],0.0016223133738696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,22509,2156,1.17 [1.03-1.33],0.0180489699056948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,22389,2145,1.75 [1.57-1.96],1.005879744301761e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG3,Secretogranin-3,22359,2146,0.84 [0.75-0.94],0.0027789616331493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,21900,2081,1.34 [1.23-1.46],1.03144673032976e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,22433,2147,1.70 [1.58-1.83],2.857928374370073e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,18890,1801,1.39 [1.27-1.51],9.584262287563684e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRIB,Protein scribble homolog,18968,1809,1.06 [1.01-1.11],0.0238389599342108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,22331,2138,1.41 [1.29-1.55],1.484440133500612e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDCCAG8,Serologically defined colon cancer antigen 8,19371,1841,1.05 [1.01-1.09],0.0213542206990766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDHB,Succinate dehydrogenase,19369,1846,1.07 [1.00-1.15],0.0455388293596113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDK2,Protein sidekick-2,19045,1813,1.13 [1.01-1.26],0.0281306965107823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEC31A,Protein transport protein Sec31A,18968,1809,1.09 [1.02-1.15],0.007118456188384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,18968,1809,1.35 [1.20-1.53],7.396454250867926e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,22606,2166,1.78 [1.65-1.92],1.004947519244607e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELL,L-selectin,19494,1852,0.57 [0.47-0.69],3.0783245797384446e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELP,P-selectin,22460,2144,1.16 [1.08-1.24],1.580852106995079e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,22279,2137,2.32 [2.00-2.68],1.2164913394139924e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,22331,2138,1.63 [1.42-1.88],1.045832856643777e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA6C,Semaphorin-6C,18885,1799,1.27 [1.08-1.49],0.0037144168868214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,22541,2159,1.80 [1.62-1.99],4.774208414705528e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN3,Neuronal-specific septin-3,19419,1844,1.06 [1.00-1.13],0.0353277369619324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA1,Alpha-1-antitrypsin,19103,1820,2.35 [1.42-3.90],0.0008537300710299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA12,Serpin A12,21660,2083,1.10 [1.06-1.13],9.980823272951737e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,19130,1810,2.10 [1.73-2.55],4.2312152953170966e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA5,Plasma serine protease inhibitor,19205,1825,1.39 [1.22-1.58],6.309207330483214e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA7,Thyroxine-binding globulin,19494,1852,1.66 [1.32-2.10],1.937254452687663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,22112,2122,1.18 [1.12-1.25],2.06836427419131e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB8,Serpin B8,22551,2158,1.08 [1.01-1.14],0.0171182938121803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,19460,1848,2.19 [1.87-2.57],4.31384248537259e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE1,Plasminogen activator inhibitor 1,22606,2166,1.21 [1.14-1.28],1.8618457967489623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,19188,1825,2.61 [2.25-3.01],2.2749756268665583e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF2,Alpha-2-antiplasmin,19117,1818,1.61 [1.15-2.25],0.0053589860066977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINH1,Serpin H1,19109,1826,1.06 [1.02-1.10],0.0010419210990266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,19017,1812,0.74 [0.63-0.86],0.0001460870458967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L2,Seizure 6-like protein 2,22222,2129,0.81 [0.69-0.96],0.0130700628791297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SF3B4,Splicing factor 3B subunit 4,22222,2129,0.95 [0.90-1.00],0.0446621535074838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,22068,2125,1.18 [1.08-1.28],0.0001887703033783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP4,Secreted frizzled-related protein 4,19045,1813,1.38 [1.24-1.55],1.6579019619460184e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,22331,2138,1.13 [1.07-1.20],9.96770637649615e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,19104,1816,1.29 [1.20-1.39],2.457759563730884e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2D1A,SH2 domain-containing protein 1A,22279,2137,1.09 [1.02-1.16],0.0091873915343488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BP1,SH3 domain-binding protein 1,19369,1846,1.09 [1.00-1.19],0.0483633998179787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,19470,1855,0.53 [0.50-0.58],2.234709851652515e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHC1,SHC-transforming protein 1,18754,1788,0.96 [0.92-1.00],0.043396451322938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,19475,1856,1.45 [1.25-1.67],8.207904664950147e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22391,2150,1.13 [1.08-1.19],6.278815598891971e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,22386,2148,1.35 [1.24-1.46],9.076096759318312e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,22429,2152,1.50 [1.38-1.64],8.431609540124321e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22279,2137,1.57 [1.42-1.72],6.800673419442645e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22355,2147,1.08 [1.04-1.11],2.090727611325361e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22508,2152,1.58 [1.42-1.76],8.251460033098939e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22331,2138,2.64 [2.32-2.99],2.509471217137476e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,18968,1809,1.47 [1.34-1.62],5.2644875194472855e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22471,2151,1.48 [1.30-1.68],1.697448963556616e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIL1,Nucleotide exchange factor SIL1,18968,1809,1.16 [1.03-1.32],0.0191016566317471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22398,2141,1.13 [1.05-1.21],0.0005539572739804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,22296,2136,1.31 [1.21-1.42],1.2381843093550408e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,21900,2081,1.58 [1.48-1.69],7.668508307453912e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,22104,2129,1.19 [1.13-1.25],1.984967825545752e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP2,Src kinase-associated phosphoprotein 2,22429,2152,1.04 [1.01-1.08],0.0193950388079348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,21900,2081,1.25 [1.17-1.33],1.5892748232036252e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,21834,2088,1.37 [1.25-1.51],1.1215233668243923e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,22279,2137,1.14 [1.07-1.22],3.2847789047874096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,21834,2088,1.33 [1.24-1.43],1.775152517896095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,21826,2083,1.13 [1.06-1.21],0.0001185673862182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC27A4,Long-chain fatty acid transport protein 4,21826,2083,1.12 [1.06-1.18],5.459796354977074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC28A1,Sodium/nucleoside cotransporter 1,18754,1788,1.11 [1.03-1.19],0.006363288870264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A14,Zinc transporter ZIP14,21826,2083,0.86 [0.76-0.97],0.0125022484974061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A5,Zinc transporter ZIP5,22279,2137,1.10 [1.02-1.18],0.008263194556445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19369,1846,1.21 [1.13-1.30],2.689111737633643e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIT2,Slit homolog 2 protein,21826,2083,1.19 [1.12-1.27],1.856777301432537e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK1,SLIT and NTRK-like protein 1,18885,1799,0.69 [0.60-0.80],3.2145145623171364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,22508,2152,1.34 [1.22-1.48],8.852375300620064e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,19369,1846,1.10 [1.04-1.16],0.0005707894993815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD1,Mothers against decapentaplegic homolog 1,21834,2088,1.09 [1.04-1.14],0.0005412693810604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,19369,1846,1.10 [1.03-1.18],0.0040115798631974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,22508,2152,1.58 [1.42-1.76],8.75513385784693e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,22429,2152,1.25 [1.13-1.37],6.39917888561769e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,22397,2149,1.37 [1.28-1.48],6.736735464135278e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD3,Sphingomyelin phosphodiesterase 3,18885,1799,0.88 [0.80-0.97],0.0128349955609885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMTN,Smoothelin,19397,1846,1.06 [1.01-1.12],0.0120829934378939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP23,Synaptosomal-associated protein 23,22331,2138,1.08 [1.04-1.13],0.0004659404745507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP29,Synaptosomal-associated protein 29,22422,2149,1.07 [1.03-1.12],0.0008362841773899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,22137,2130,1.20 [1.13-1.27],2.9189456896242724e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",18968,1809,1.35 [1.20-1.53],1.28805891221601e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',19425,1849,1.17 [1.08-1.28],0.0001417233969694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNU13,NHP2-like protein 1,18799,1796,0.92 [0.85-0.99],0.032621048161701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX9,Sorting nexin-9,22331,2138,1.06 [1.00-1.12],0.0369995292338789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",22355,2147,1.24 [1.13-1.36],5.963771885829453e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD3,Extracellular superoxide dismutase,19470,1855,0.88 [0.81-0.96],0.0039981704802065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORBS1,Sorbin and SH3 domain-containing protein 1,19419,1844,1.14 [1.04-1.25],0.0075415395966886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,21834,2088,1.24 [1.12-1.38],4.684315262004794e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,22402,2142,1.36 [1.29-1.44],3.513195261170237e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,22288,2136,1.39 [1.26-1.54],9.740997978513751e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOST,Sclerostin,22288,2136,1.24 [1.12-1.36],2.4319548076774712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARCL1,SPARC-like protein 1,22387,2137,0.74 [0.64-0.85],2.321642964051975e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,22355,2147,1.62 [1.50-1.74],3.488216951471037e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK2,Serine protease inhibitor Kazal-type 2,19045,1813,0.81 [0.72-0.92],0.0007925178011389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,22279,2137,1.40 [1.33-1.48],2.7161157886672203e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK5,Serine protease inhibitor Kazal-type 5,22355,2147,0.86 [0.77-0.96],0.0075300872110276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK6,Serine protease inhibitor Kazal-type 6,22508,2152,1.12 [1.04-1.20],0.0026985129992124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,22287,2141,1.73 [1.51-1.97],5.59136176824987e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,22429,2152,1.34 [1.21-1.47],3.0304139084636203e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT3,Kunitz-type protease inhibitor 3,19369,1846,0.96 [0.93-0.99],0.0088709282445065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,22137,2130,0.82 [0.70-0.95],0.0076829321305066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,22359,2146,1.61 [1.46-1.78],4.997679031927407e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,22224,2131,1.89 [1.70-2.10],1.8400409395908714e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPP1,Osteopontin,22580,2163,0.91 [0.84-0.99],0.022133724266521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRP14,Signal recognition particle 14 kDa protein,22222,2129,1.15 [1.08-1.22],1.5712735271541695e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPK2,SRSF protein kinase 2,22279,2137,1.07 [1.02-1.12],0.0038254259927799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22288,2136,1.17 [1.14-1.21],2.8840778783924554e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22460,2144,1.80 [1.64-1.96],8.299367995449601e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22222,2129,0.87 [0.79-0.96],0.0052734006216938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22606,2166,1.55 [1.38-1.73],7.51402027501092e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,19475,1856,1.93 [1.65-2.26],2.2327843467098913e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,22509,2156,1.45 [1.34-1.57],5.506604772257279e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC2,Stanniocalcin-2,22328,2144,1.43 [1.22-1.67],1.1198992370959574e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK11,Serine/threonine-protein kinase STK11,21913,2105,1.08 [1.02-1.14],0.004838921830843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX16,Syntaxin-16,21834,2088,1.10 [1.03-1.17],0.0071221195056625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX1B,Syntaxin-1B,18933,1813,0.82 [0.72-0.93],0.0017854831291315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX4,Syntaxin-4,22222,2129,1.13 [1.07-1.20],5.06290791459729e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX8,Syntaxin-8,22279,2137,1.12 [1.04-1.22],0.0045915473216544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,22279,2137,1.40 [1.33-1.48],1.340910651602585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22509,2156,1.25 [1.16-1.34],8.353704666667118e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",19419,1844,1.33 [1.25-1.42],1.0583906317041909e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD1,Sushi domain-containing protein 1,21913,2105,1.08 [1.00-1.17],0.0483008983699779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,22355,2147,1.19 [1.05-1.36],0.0080710067633014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,18934,1805,0.57 [0.50-0.65],4.72074997140161e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SV2A,Synaptic vesicle glycoprotein 2A,18933,1813,1.10 [1.02-1.17],0.0102069453600366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYT1,Synaptotagmin-1,19425,1849,0.86 [0.76-0.97],0.0156059635099483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYTL4,Synaptotagmin-like protein 4,19462,1849,1.07 [1.01-1.13],0.0299992844965735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TALDO1,Transaldolase,19389,1850,1.33 [1.21-1.47],1.2112664787722009e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TANK,TRAF family member-associated NF-kappa-B activator,21900,2081,1.11 [1.05-1.17],0.0004759323914176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARBP2,RISC-loading complex subunit TARBP2,21826,2083,1.07 [1.01-1.12],0.0116198600813946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",18933,1813,0.92 [0.86-0.98],0.0064920524503397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAX1BP1,Tax1-binding protein 1,19425,1849,1.14 [1.07-1.22],0.0001787954499292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D5,TBC1 domain family member 5,22279,2137,1.05 [1.00-1.10],0.0474816406458406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCL1B,T-cell leukemia/lymphoma protein 1B,21913,2105,1.05 [1.00-1.10],0.0295890199316156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN1,Transcobalamin-1,19068,1809,1.18 [1.05-1.33],0.0065882076706373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,22580,2163,1.68 [1.50-1.87],7.930799874093805e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,19462,1849,1.50 [1.33-1.68],1.0935357515007532e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCTN3,Tectonic-3,19462,1849,1.56 [1.35-1.81],3.4142952095471803e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDRKH,Tudor and KH domain-containing protein,21826,2083,1.10 [1.05-1.15],4.501351422071729e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,22422,2149,2.33 [1.97-2.76],1.951721201741788e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,19494,1852,2.01 [1.64-2.47],1.9345759926015168e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,22238,2137,1.26 [1.20-1.31],3.3222935372269486e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,22391,2150,1.45 [1.37-1.54],3.699953956196583e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,22336,2127,1.47 [1.36-1.58],4.27408346745122e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI,Tissue factor pathway inhibitor,22310,2134,0.84 [0.74-0.96],0.0080680039038005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,22363,2144,1.18 [1.09-1.28],7.404493515631676e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,22447,2142,1.17 [1.06-1.29],0.0021586400964282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TG,Thyroglobulin,19371,1841,0.92 [0.88-0.96],3.860408783300313e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,22279,2137,1.51 [1.40-1.63],6.173245812033746e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,22519,2155,1.43 [1.30-1.56],5.513756589282063e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22237,2125,1.23 [1.07-1.41],0.0040587089363605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,22422,2149,1.34 [1.21-1.48],2.164808932478856e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR3,Transforming growth factor beta receptor type 3,22606,2166,0.71 [0.63-0.79],1.915000710917941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,22331,2138,1.21 [1.07-1.38],0.002862834175886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,22355,2147,2.00 [1.85-2.16],3.605899983443677e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS4,Thrombospondin-4,22375,2141,1.22 [1.13-1.33],1.876011928225004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,22210,2133,1.53 [1.36-1.71],4.682308820754152e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THPO,Thrombopoietin,21913,2105,0.84 [0.76-0.93],0.00056603320343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,22509,2156,1.33 [1.17-1.51],8.615783450087895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIE1,Tyrosine-protein kinase receptor Tie-1,22606,2166,1.20 [1.09-1.32],0.0003218014017115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21793,2082,1.13 [1.04-1.23],0.002970939368025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19109,1826,1.17 [1.05-1.31],0.0060845743753622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,22127,2107,1.87 [1.66-2.11],1.9822759767256124e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP3,Metalloproteinase inhibitor 3,22429,2152,1.07 [1.04-1.10],6.689983034533094e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,22355,2147,0.67 [0.61-0.74],1.1789807382673464e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJAP1,Tight junction-associated protein 1,22422,2149,1.05 [1.00-1.10],0.0379727042085225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,18885,1799,1.36 [1.16-1.59],0.0001867119013143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,22551,2158,1.29 [1.21-1.38],6.819276514230061e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,22222,2129,1.30 [1.25-1.36],1.6320943178636827e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS5,Transmembrane protease serine 5,22039,2122,0.85 [0.77-0.94],0.0015287646903386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMSB10,Thymosin beta-10,22355,2147,1.07 [1.01-1.13],0.0123272355560699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNC,Tenascin,22460,2144,0.84 [0.77-0.90],6.8841569881910994e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,21885,2103,1.31 [1.21-1.42],2.7263404756572888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22137,2130,1.98 [1.83-2.14],1.5500439557444015e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22137,2130,1.37 [1.31-1.44],4.591111005461066e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22412,2148,1.15 [1.07-1.25],0.0004156727656381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22551,2158,1.91 [1.76-2.08],1.9406717346617734e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22325,2139,2.16 [1.92-2.43],1.987852791481956e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22422,2149,1.77 [1.61-1.95],1.3942357968014668e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22359,2146,1.18 [1.07-1.31],0.0011206568826471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22359,2146,1.60 [1.43-1.80],1.2965650195944644e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19045,1813,0.89 [0.80-0.99],0.0279854901509535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22355,2147,1.90 [1.70-2.12],8.908878351666518e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22355,2147,1.41 [1.31-1.51],1.667979484937558e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22519,2155,1.44 [1.32-1.58],1.6322042692878213e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22137,2130,1.27 [1.20-1.35],7.760481649979837e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22137,2130,1.25 [1.15-1.35],8.488266812293159e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22551,2158,0.49 [0.43-0.57],5.954209790045877e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22279,2137,0.77 [0.72-0.82],6.017812777335185e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22551,2158,0.48 [0.42-0.55],1.3893480447401207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22429,2152,1.53 [1.34-1.76],6.610860797422885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22577,2164,1.47 [1.29-1.66],3.047113770472379e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22137,2130,1.16 [1.08-1.24],1.5780660357808282e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19475,1856,1.39 [1.24-1.57],2.5400344834740745e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNIP1,TNFAIP3-interacting protein 1,19425,1849,1.07 [1.02-1.12],0.0101398267494291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,19475,1856,1.39 [1.25-1.53],3.1700306160236525e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,22355,2147,0.72 [0.62-0.83],1.0307419023980417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19462,1849,1.13 [1.06-1.19],3.4516954667788554e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1,DNA topoisomerase 1,19369,1846,1.07 [1.03-1.11],0.000730047000624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP2B,DNA topoisomerase 2-beta,18885,1799,1.09 [1.03-1.16],0.0023812873405896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOR1AIP1,Torsin-1A-interacting protein 1,18968,1809,1.12 [1.04-1.22],0.0050201514715184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53I3,Quinone oxidoreductase PIG3,18635,1766,1.28 [1.17-1.39],1.4540209504982976e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,19462,1849,0.47 [0.40-0.55],1.6600946542304261e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,22170,2126,1.50 [1.40-1.61],5.405678685752478e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP3,Tubulin polymerization-promoting protein family member 3,21826,2083,0.85 [0.76-0.95],0.0036584877123316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPR,Nucleoprotein TPR,18799,1796,1.16 [1.07-1.26],0.000279795026105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSAB1,Tryptase alpha/beta-1,22518,2157,1.12 [1.04-1.20],0.002810310968332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,19475,1856,1.53 [1.44-1.63],1.3484723851304843e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,22325,2139,1.29 [1.21-1.38],2.1825707399908866e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22508,2152,1.07 [1.00-1.14],0.0395944079460847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM24,Transcription intermediary factor 1-alpha,19079,1824,1.07 [1.00-1.15],0.0493354625736635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM5,Tripartite motif-containing protein 5,22279,2137,1.06 [1.01-1.11],0.0091707913315579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,19371,1841,1.07 [1.02-1.13],0.0102719016799197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSHB,Thyrotropin subunit beta,22331,2138,0.93 [0.89-0.98],0.0047493132680324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN8,Tetraspanin-8,19369,1846,1.07 [1.03-1.12],0.0022963232031487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXLNA,Alpha-taxilin,22137,2130,1.10 [1.05-1.15],1.992636975913848e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC5,Thioredoxin domain-containing protein 5,22509,2156,1.11 [1.05-1.18],0.0001299926177976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22355,2147,1.27 [1.17-1.37],1.3856871382714996e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYMP,Thymidine phosphorylase,22182,2121,1.11 [1.05-1.18],0.0006081831150631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",18885,1799,1.13 [1.05-1.21],0.000754253653881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,22137,2130,1.46 [1.33-1.60],3.043063411988817e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,22546,2156,0.70 [0.65-0.74],1.4601369476057702e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,19462,1849,1.48 [1.42-1.54],2.6108924286245368e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROD,Uroporphyrinogen decarboxylase,19045,1813,1.10 [1.03-1.17],0.005957778685066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USO1,General vesicular transport factor p115,22222,2129,1.04 [1.00-1.09],0.0460487723378939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19371,1841,1.08 [1.01-1.15],0.0196987936777751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,21913,2105,1.05 [1.01-1.10],0.015175698865236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP5,Vesicle-associated membrane protein 5,21913,2105,1.10 [1.03-1.18],0.0039912849279382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22279,2137,1.05 [1.00-1.10],0.0497032407230128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22222,2129,0.45 [0.37-0.55],7.446401711518236e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,22412,2141,1.54 [1.35-1.76],2.153088636817708e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAN,Versican core protein,22509,2156,0.72 [0.63-0.81],3.172197635696066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,22480,2150,1.24 [1.17-1.33],1.2547300794859496e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFD,Vascular endothelial growth factor D,22516,2155,1.14 [1.02-1.26],0.0156606121881595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VGF,Neurosecretory protein VGF,19419,1844,0.78 [0.67-0.90],0.0007474173849335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,22222,2129,1.31 [1.23-1.39],1.5242595615977265e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,19470,1855,1.35 [1.26-1.44],2.745715844845212e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN2,Vascular non-inflammatory molecule 2,22222,2129,1.30 [1.19-1.42],2.9290980253583193e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS37A,Vacuolar protein sorting-associated protein 37A,22222,2129,1.08 [1.03-1.13],0.0016706765231653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22222,2129,1.05 [1.00-1.11],0.0370827572334165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,19371,1841,1.42 [1.34-1.51],1.4451861381350286e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,22328,2144,1.52 [1.40-1.66],8.770876840996837e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22292,2135,1.12 [1.05-1.19],0.0002376424538222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSNL1,Visinin-like protein 1,19425,1849,1.42 [1.28-1.58],7.535672964894647e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,21913,2105,1.25 [1.18-1.32],4.209154088892692e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,21834,2088,1.22 [1.08-1.37],0.0011468313250493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19045,1813,1.08 [1.00-1.17],0.0476465951553235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA1,von Willebrand factor A domain-containing protein 1,22470,2148,1.29 [1.18-1.41],5.912727166590446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,22068,2128,1.16 [1.06-1.27],0.0019219645561178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,19419,1844,0.74 [0.65-0.83],1.0347832308469211e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWF,von Willebrand factor,22606,2166,1.12 [1.07-1.18],1.2919576165358389e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22355,2147,1.15 [1.04-1.27],0.0082610662765965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,21913,2105,1.05 [1.01-1.10],0.0136740111346662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASHC3,WASH complex subunit 3,19425,1849,1.07 [1.01-1.14],0.0194930443602268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASL,Neural Wiskott-Aldrich syndrome protein,18885,1799,0.92 [0.85-1.00],0.0400223488291823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC1,WAP four-disulfide core domain protein 1,18973,1804,1.12 [1.04-1.20],0.0033001415645681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,21224,2030,1.41 [1.29-1.53],6.8956420638011876e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22359,2146,0.68 [0.61-0.77],4.592071681645842e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,22508,2152,0.56 [0.50-0.63],4.647658687685578e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22137,2130,1.11 [1.03-1.19],0.0059772969190901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,22508,2152,1.13 [1.06-1.21],0.0001223610931654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,22422,2149,0.93 [0.90-0.97],0.0002385815541042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XRCC4,DNA repair protein XRCC4,21826,2083,1.13 [1.02-1.25],0.0167165071302849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,19425,1849,1.29 [1.11-1.50],0.0011889018573314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19369,1846,1.04 [1.01-1.08],0.009144261572138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YES1,Tyrosine-protein kinase Yes,22222,2129,1.06 [1.02-1.09],0.0013592380323343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YTHDF3,YTH domain-containing family protein 3,21900,2081,1.06 [1.01-1.11],0.009322665730727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,21834,2088,1.08 [1.03-1.14],0.0030699990496349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,21913,2105,1.18 [1.09-1.28],4.027007861638249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZHX2,Zinc fingers and homeoboxes protein 2,19425,1849,1.22 [1.09-1.37],0.0005737399658825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,19369,1846,1.16 [1.09-1.23],3.5893600942467748e-06
